"Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation
artículo científico publicado en 2016
'Aspirin resistance' or treatment non-compliance: which is to blame for cardiovascular complications?
artículo científico publicado en 2008
'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation
artículo científico publicado en 2007
'Lone' atrial fibrillation: no longer lone or even alone
artículo científico publicado en 2015
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey
artículo científico publicado en 2014
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase
artículo científico publicado en 2016
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry
artículo científico publicado en 2016
'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin
artículo científico publicado en 2019
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population
artículo científico publicado en 2018
124 South Asian Ethnicity is Independently Related to Diastolic Function in Hypertension: Abstract 124 Table 1
artículo científico publicado en 2015
125 Monocyte subpopulation counts and functional characteristics predict adverse clinical events post ST elevation myocardial infarction: Abstract 125 Table 1
article by A A Ghattas et al published May 2012 in Heart
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
artículo científico publicado en 2007
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
article
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati
artículo científico publicado en 2015
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the Eur
artículo científico publicado en 2015
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):
artículo científico publicado en 2015
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
article by Paulus Kirchhof et al published 27 August 2016 in EP Europace
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
artículo científico publicado en 2016
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
artículo científico publicado en 2016
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiol
article
2016 European Guidelines on cardiovascular disease prevention in clinical practice
artículo científico publicado en 2016
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
artículo científico publicado en 2017
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
artículo científico publicado en 2017
2018 ESC/ESH Guidelines for the management of arterial hypertension
artículo científico publicado en 2018
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the
article
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension
article by Bryan Williams et al published December 2018 in Journal of Hypertension
2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
artículo científico publicado en 2020
243 MONOCYTE SUBPOPULATION COUNTS AND TNF ALPHA ASSOCIATIONS WITH CLINICAL OUTCOME POST ST ELEVATION MYOCARDIAL INFARCTION
26 Digoxin – Friend or Foe? A Comprehensive Review of Digoxin use and Mortality
artículo científico publicado en 2015
34 Ethnic and Gender Differences in Symptom-to-Door Times in Patients Presenting with St Elevation Myocardial Infarction
artículo científico publicado en 2014
45 Rivaroxaban vs. dabigatran or warfarin in real-world observational studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis
artículo científico publicado en 2017
92 High heart rate predicts cardiac fibrosis in patients with atrial fibrillation and preserved left ventricular function
artículo científico publicado en 2018
97 Total monocyte count as predictor of exercise capacity in patients with permanent atrial fibrillation and preserved left ventricular function – the west birmingham AF project
artículo científico publicado en 2018
A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study
artículo científico
A Happy New Year from a 60-Year-Old Journal 'Thrombosis and Haemostasis'!
artículo científico publicado en 2018
A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation
artículo científico publicado en 2020
A Nurse-led Atrial Fibrillation Clinic: Impact on Anticoagulation Therapy and Clinical Outcomes
artículo científico publicado en 2020
A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients
artículo científico publicado en 2016
A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in
scientific article published on 15 July 2015
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials
scientific article published on 02 May 2018
A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects
article
A Time to Stop and Think Before the Shock
artículo científico publicado en 2019
A Toast to the Last Decade and a Very Happy 2020 from Thrombosis and Haemostasis!
artículo científico publicado en 2020
A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry
artículo científico publicado en 2018
A brief history of 'lone' atrial fibrillation: from 'a peculiar pulse irregularity' to a modern public health concern
artículo científico
A case of breathlessness
artículo científico publicado en 2003
A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study
artículo científico publicado en 2013
A comparison of plasma versus histologic indices of angiogenic markers in breast cancer
scientific article published on 01 December 2007
A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
⬇️
artículo científico publicado el 1 de enero de 2011
A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: the West Birmingham Malignant Hypertension project.
artículo científico publicado en 2011
A comprehensive insight of novel antioxidant therapies for atrial fibrillation management
artículo científico publicado en 2015
A contemporary view on endothelial function in heart failure
artículo científico publicado en 2012
A contemporary viewpoint on 'aspirin resistance'.
artículo científico publicado en 2012
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial
artículo científico publicado en 2007
A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study
artículo científico publicado en 2012
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation
artículo científico publicado en 2015
A drug safety evaluation of apixaban for the treatment of atrial fibrillation, acute coronary syndrome, and percutaneous coronary intervention
artículo científico publicado en 2019
A greater burden of atrial fibrillation is associated with worse endothelial dysfunction in hypertension
artículo científico publicado en 2020
A happy and prosperous New Year 2017 with "Thrombosis and Haemostasis" …. and our 60th Anniversary!
artículo científico publicado en 2017
A happy new year 2013 for Thrombosis and Haemostasis
A happy new year from Thrombosis and Haemostasis. A 5 year reflection from the editorial team
artículo científico publicado en 2015
A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice
artículo científico
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score
artículo científico publicado en 2020
A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices
artículo científico
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
artículo científico publicado en 2010
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
artículo científico publicado en 2005
A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme
artículo científico publicado en 2016
A prophylactically implanted cardioverter defibrillator did not reduce all-cause mortality after a recent myocardial infarction
artículo científico
A proposal for new clinical concepts in the management of atrial fibrillation
artículo científico
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
artículo científico publicado en 2015
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation
artículo científico publicado en 2002
A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
artículo científico publicado en 2014
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
artículo científico publicado en 2013
A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]
artículo científico publicado en 2004
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
artículo científico publicado en 2005
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers i
article
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
artículo científico publicado en 2004
A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study
artículo científico publicado en 2009
A reliable plasma marker of platelet activation: does it exist?
artículo científico publicado en 2002
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial
artículo científico publicado en 2017
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
artículo científico publicado en 2015
A simple clinical risk score (CHEST) for predicting incident atrial fibrillation in Asian subjects: Derivation in 471,446 Chinese subjects, with internal validation and external application in 451,199 Korean subjects
article
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
artículo científico publicado en 2002
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
artículo científico
A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes
artículo científico publicado en 2007
A systematic review of the prothrombotic effects of an acute change in posture: a possible mechanism underlying the morning excess in cardiovascular events?
artículo científico publicado en 2007
A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation
artículo científico publicado en 2016
A very happy new year 2014 from Thrombosis and Haemostasis! Reflections on the past, the present and the future.
artículo científico publicado en 2014
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study
artículo científico publicado en 2019
ABC of antithrombotic therapy: An overview of antithrombotic therapy
artículo científico publicado en 2002
ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders
artículo científico publicado en 2002
ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina
artículo científico publicado en 2002
ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions
artículo científico publicado en 2003
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies
artículo científico publicado en 2002
ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
artículo científico publicado en 2020
ACP Journal Club. Ablation reduced recurrent atrial tachyarrhythmia more than antiarrhythmic drugs in paroxysmal AF
artículo científico publicado en 2014
ACP Journal Club. PCI in noninfarction arteries reduced cardiac events in acute STEMI with multivessel coronary disease
artículo científico publicado en 2013
ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure
scientific article published on August 2009
ACP Journal Club. The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation
artículo científico publicado en 2016
ALGORITHM FOR THE MANAGEMENT OF ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: AN UPDATED PROPOSAL BASED ON EFFICACY CONSIDERATIONS
scientific article published on 14 January 2020
ANTITHROMBOTIC TREATMENT IN RELATION TO AGE IN PATIENTS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION IN NORTH AMERICA (GLORIA-AF PHASE II)
artículo científico publicado en 2015
AZD6140 and bleeding: towards safer antiplatelet therapy?
artículo científico publicado en 2009
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease
artículo científico publicado en 2006
Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis
scientific article published on 01 January 2006
Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial
artículo científico publicado en 2007
Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?
artículo científico publicado en 2013
Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS
Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012
Acute Kidney Injury and Postoperative Atrial Fibrillation In Patients Undergoing Cardiac Surgery
artículo científico publicado en 2020
Acute Management of Atrial Fibrillation: Response
artículo científico publicado en 2009
Acute atrial fibrillation
artículo científico publicado en 2002
Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?
artículo científico publicado en 2004
Acute coronary syndromes: Virchow's triad revisited
artículo científico publicado el 1 de octubre de 2003
Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes
artículo científico publicado en 2009
Acute hydrocortisone administration reduces cardiovagal baroreflex sensitivity and heart rate variability in young men
artículo científico publicado en 2018
Acute ischaemic stroke management: Concepts and Controversies. A narrative review
artículo científico publicado en 2020
Acute management of atrial fibrillation
artículo científico publicado en 2009
Acute management of atrial fibrillation with acute haemodynamic instability and in the postoperative setting
artículo científico publicado en 2006
Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study
artículo científico publicado en 2014
Acute versus habitual exercise, thrombogenesis and exercise intensity
scientific article published on 01 March 2004
Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study
artículo científico publicado en 2012
Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation
artículo científico publicado en 2017
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation
artículo científico publicado en 2006
Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry
artículo científico publicado en 2020
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study
artículo científico publicado en 2016
Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants
artículo científico publicado en 2016
Adherence to the ABC (Atrial fibrillation Better Care) pathway in the Balkan region: the BALKAN-AF survey
scientific article published on 17 January 2020
Admissions with atrial fibrillation in a multiracial population in Kuala Lumpur, Malaysia
⬇️
artículo científico publicado el 1 de octubre de 2003
Advances in therapy for atrial fibrillation
artículo científico publicado en 2010
Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation
scientific article published on 27 September 2011
Adverse cardiovascular outcomes in relation to suboptimal antithrombotic therapy use in patients undergoing peripheral artery disease angioplasty: lost opportunities?
artículo científico publicado en 2014
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation
artículo científico publicado en 2016
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan
artículo científico publicado en 2015
Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation
artículo científico publicado en 2018
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants
scientific article published on 30 June 2013
Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis
artículo científico publicado en 2010
Age dependence of risk factors for stroke and death in young patients with atrial fibrillation: a nationwide study
artículo científico publicado en 2014
Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities
artículo científico publicado en 2019
Age- and sex-specific analysis of patients with embolic stroke of undetermined source
artículo científico publicado en 2017
Age-Dependent Prognostic Impact of Paroxysmal Versus Sustained Atrial Fibrillation on the Incidence of Cardiac Death and Heart Failure Hospitalization (the Fushimi AF Registry)
scientific article published on 07 August 2019
Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe
Age-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: The EORP-AF General Pilot Registry (EURObservational Research Programme-Atrial Fibrillation)
Age-dependent anticoagulant therapy for atrial fibrillation patients with intermediate risk of ischemic stroke: A nationwide population-based study
scientific article published on 11 December 2020
Airborne occupational exposure and ABO phenotype: an example of gene-environment interaction in ischaemic heart disease?
artículo científico publicado en 2002
Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes without Cardiovascular Disease: A Danish Cohort Study
scientific article published on 20 March 2020
Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension--does it matter? (no!).
artículo científico publicado en 2003
Alcohol and hypertension: an old relationship revisited
artículo científico publicado en 2005
Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review
artículo científico publicado en 2009
Alcohol intake and prognosis of atrial fibrillation
artículo científico publicado en 2013
All Types of Hemorrhagic Stroke Are Not Created Equally-Reply
artículo científico publicado en 2017
Alpha 1-microglobulin: a further insight into inflammation in hypertension?
scientific article published on 01 September 2007
Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease
artículo científico publicado en 2002
Altered Blood Vessel Responses in the Eye and Finger in Coronary Artery Disease
article
Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function
artículo científico publicado en 2016
Ambulatory blood pressure and long-term risk for atrial fibrillation
artículo científico publicado en 2018
Ambulatory blood pressure in atrial fibrillation: an irregular conundrum of rate and rhythm
artículo científico publicado en 2013
Ambulatory blood pressure monitoring in heart failure: a systematic review
artículo científico publicado en 2005
An "unlikely" Wells rule score (≤ 1) plus a negative D-dimer result excluded DVT in noncancer patients
article by Richard A Brown & Gregory Lip published 1 July 2014 in Annals of Internal Medicine
An 8-year follow-up study of acute admissions with heart failure in a multiethnic population
artículo científico publicado en 2004
An analysis of factors that predict patient consent to take part in a randomized controlled trial
artículo científico publicado en 2007
An epidemic of atrial fibrillation?
artículo científico publicado en 2011
An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization
artículo científico publicado en 2010
An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium
artículo científico publicado en 2012
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality
artículo científico publicado en 2010
An interview with Professor Gregory Lip
scientific article published on 10 April 2020
An observational study of endothelial function in early arthritis
artículo científico publicado en 2011
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary interv
artículo científico publicado en 2014
An update on atrial fibrillation: focus on stroke risk reduction strategies
artículo científico publicado en 2015
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting
artículo científico publicado en 2008
Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients
artículo científico publicado en 2014
Anger rumination, social support, and cardiac symptoms in patients undergoing angiography
artículo científico publicado en 2010
Angiogenesis in myocardial infarction. An acute or chronic process?
artículo científico publicado en 2002
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease
artículo científico publicado en 2003
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
scientific article published on 01 January 2005
Angiogenin and apoptosis in hypertension in pregnancy
artículo científico
Angiogenin and hemoxygenase in pregnancy: influence of hypertension.
artículo científico publicado en 2011
Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer
artículo científico publicado en 2013
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
artículo científico publicado en 2004
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension
artículo científico publicado en 2008
Angiopoietins and preeclampsia: new perspectives in the quest for markers
artículo científico publicado en 2009
Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?
artículo científico publicado en 2009
Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins
artículo científico publicado en 2005
Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?
artículo científico
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation
artículo científico publicado en 2012
Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.
artículo científico publicado en 2016
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure
artículo científico publicado en 2003
Anti-platelet therapy: is it all over in peripheral artery disease?
scientific article published on 19 February 2010
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment
artículo científico publicado en 2005
Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone
scientific article published on May 2009
Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility
artículo científico publicado en 2004
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhyth
artículo científico publicado en 2018
Antiarrhythmics in atrial fibrillation.
artículo científico publicado en 2002
Anticoagulación oral en pacientes con fibrilación auricular e insuficiencia renal terminal: ¿qué es lo más apropiado? Respuesta
artículo científico publicado en 2019
Anticoagulant Selection in Relation to SAMe-TT<sub>2</sub>R<sub>2</sub> Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry
artículo científico publicado en 2020
Anticoagulant Therapy in Initially Low-Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors
artículo científico publicado en 2020
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis
artículo científico publicado en 2008
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline
artículo científico publicado en 2006
Anticoagulant therapy after venous thromboembolism and 10-year mortality
artículo científico publicado en 2016
Anticoagulant treatment is effective in atrial fibrillation
artículo científico publicado en 2013
Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?
artículo científico publicado en 2014
Anticoagulants as anticancer agents?
artículo científico publicado en 2002
Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
artículo científico publicado en 2017
Anticoagulation Issues
Anticoagulation Resumption After Intracerebral Hemorrhage.
artículo científico publicado en 2018
Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification
scientific article published on 01 October 2005
Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation
artículo científico publicado en 2020
Anticoagulation control with vitamin K antagonists: how well are we doing?
artículo científico publicado en 2006
Anticoagulation for atrial fibrillation patients with CHADS score of 1
artículo científico publicado en 2010
Anticoagulation for elderly patients with atrial fibrillation: not to be neglected
artículo científico publicado en 2007
Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review
artículo científico publicado en 2002
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
artículo científico publicado en 2006
Anticoagulation for stroke prevention: high effectiveness, more cost benefit?
artículo científico publicado en 2006
Anticoagulation in Atrial Fibrillation
artículo científico publicado en 2012
Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range
Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act
artículo científico publicado en 2018
Anticoagulation in hospitals and general practice
artículo científico publicado en 2003
Anticoagulation intensity for elderly atrial fibrillation patients: should we use a conventional INR target (2.0 to 3.0) or a lower range?
artículo científico publicado en 2010
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions
artículo científico publicado en 2013
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
artículo científico publicado en 2006
Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
artículo científico publicado en 2015
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice
artículo científico publicado en 2010
Anticoagulation uptake in emergency department patients with atrial fibrillation
artículo científico publicado en 2003
Anticoagulation variability: is it the physician, patient or hospital?
artículo científico publicado en 2009
Anticoagulation versus placebo for heart failure in sinus rhythm
artículo científico publicado en 2014
Anticoagulation versus placebo for heart failure in sinus rhythm
artículo científico publicado en 2012
Antidotes to non-vitamin K oral anticoagulants: necessary or not?
artículo científico publicado en 2015
Antihypertensive therapy and endothelial function
artículo científico publicado en 2004
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
scholarly article by Morten Lamberts et al published 15 April 2014 in Circulation
Antiplatelet agents and anticoagulants for hypertension
artículo científico publicado en 2011
Antiplatelet agents and anticoagulants for hypertension
artículo científico publicado en 2004
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm
artículo científico publicado en 2016
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review
artículo científico publicado en 2002
Antiplatelet and Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Coronary Stenting
artículo científico publicado en 2017
Antiplatelet and anticoagulant therapy in patients with advanced heart failure
artículo científico publicado en 2005
Antiplatelet therapy and anticoagulants
artículo científico publicado en 2013
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality
artículo científico publicado en 2018
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.
artículo científico publicado en 2012
Antiplatelet therapy in stroke prevention
artículo científico
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
artículo científico publicado en 2016
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report
scientific article published on 22 August 2018
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, E
artículo científico publicado en 2017
Antithrombotic Therapy in Hypertension
Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study
scientific article published on 16 March 2019
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
artículo científico publicado en 2015
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
artículo científico publicado en 2016
Antithrombotic and anticoagulant therapy for atrial fibrillation
artículo científico publicado en 2014
Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention
artículo científico publicado en 2012
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Soc
article
Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?
artículo científico publicado en 2015
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorse
artículo científico publicado en 2010
Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions
artículo científico publicado en 2002
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI
scientific article published on 01 December 2020
Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding
artículo científico publicado en 2011
Antithrombotic therapy for atrial fibrillation
artículo científico publicado en 2002
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
artículo científico publicado en 2012
Antithrombotic therapy for congestive heart failure
artículo científico publicado en 2006
Antithrombotic therapy for heart failure in sinus rhythm
artículo científico publicado en 2009
Antithrombotic therapy in acute coronary syndromes
artículo científico publicado en 2002
Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting
artículo científico publicado en 2010
Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy
scientific article published on 29 August 2013
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Wo
artículo científico publicado en 2017
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
artículo científico publicado en 2008
Antithrombotic therapy in hypertension: a Cochrane Systematic review
artículo científico publicado en 2005
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
artículo científico publicado en 2008
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and/or undergoing a percutaneous coronary intervention
artículo científico publicado en 2020
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
artículo científico publicado en 2004
Antithrombotic therapy in peripheral vascular disease
artículo científico publicado en 2002
Antithrombotic therapy in special circumstances. I--pregnancy and cancer
artículo científico publicado en 2003
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.
artículo científico
Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
artículo científico publicado en 2008
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence
artículo científico publicado en 2009
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I c
artículo científico publicado en 2016
Antithrombotic therapy: standard therapy in essential hypertension?
artículo científico publicado en 2006
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme
artículo científico publicado en 2020
Antithrombotic treatment in atrial fibrillation
artículo científico publicado en 2005
Antithrombotic treatment in atrial fibrillation
artículo científico publicado en 2006
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis
artículo científico publicado en 2020
Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey
artículo científico publicado en 2019
Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study
artículo científico publicado en 2014
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
artículo científico publicado en 2006
Anxiety, depression, and prognosis after myocardial infarction: is there a causal association?
artículo científico publicado en 2003
Aortic coarctation and twin pregnancy
scientific article published on 01 May 2011
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
artículo científico publicado en 2018
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
artículo científico publicado en 2019
Apixaban in Patients with Atrial Fibrillation
⬇️
artículo científico publicado el 10 de febrero de 2011
Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation
artículo científico publicado en 2017
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
artículo científico publicado en 2012
Apixaban versus edoxaban for stroke prevention in nonvalvular atrial fibrillation
artículo científico
Apixaban, an oral, direct inhibitor of activated Factor Xa.
artículo científico publicado en 2008
Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease
artículo científico publicado en 2010
Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients
artículo científico publicado en 2016
Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study
artículo científico publicado en 2020
Are Alpha-Adrenergic Receptor Antagonists Beneficial to Prevent Heart Failure?: Alpha-Adrenergic Receptor Antagonists Revisited
artículo científico publicado en 2018
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies
artículo científico publicado en 2011
Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
artículo científico publicado en 2020
Are guidelines on cardiovascular risk prevention comprehensive enough? Focus on the 2005 Joint British Societies? Guidelines
artículo científico publicado en 2006
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain
artículo científico publicado en 2005
Arrhythmias and cognitive function
artículo científico publicado en 2018
Arterial disease and venous thromboembolism: a modern paradigm?
artículo científico publicado en 2006
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation
artículo científico publicado en 2018
Arterial stiffness: beyond pulse wave velocity and its measurement
artículo científico publicado en 2008
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial
artículo científico publicado en 2017
Aspirin and aspirin resistance in coronary artery disease
artículo científico publicado en 2013
Aspirin and endothelial function in hypertension
artículo científico publicado en 2005
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease
artículo científico publicado en 2016
Aspirin for prevention of stroke in atrial fibrillation
artículo científico publicado en 2006
Aspirin resistance: what, why and when?
artículo científico publicado en 2007
Aspirin--a drug whose time has gone?
artículo científico publicado en 2010
Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation
artículo científico publicado en 2014
Assessing Bleeding Risk With the HAS-BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding-Risk Assessment
artículo científico publicado en 2015
Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial
artículo científico publicado en 2017
Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation--Reply
artículo científico publicado en 2015
Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor based approach
artículo científico publicado en 2020
Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project
artículo científico publicado en 2016
Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors
artículo científico publicado en 2015
Assessing the Performance of the HAS-BLED Score: Response
artículo científico publicado en 2011
Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
artículo científico publicado en 2012
Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?
scientific article published on 01 February 2020
Assessment of atrial fibrosis for the rhythm control of atrial fibrillation
⬇️
artículo científico publicado en 2016
Assessment of endothelial (dys)function in atrial fibrillation
artículo científico publicado en 2009
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor
artículo científico publicado en 2004
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells
artículo científico publicado en 2007
Assessment of endothelial dysfunction
scientific article published on April 2010
Assessment of endothelial function: implications for hypertension and cardiovascular disorders
artículo científico publicado en 2009
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
artículo científico publicado en 2012
Assessment of hemostatic risk factors in predicting arterial thrombotic events
scientific article published on 01 February 2006
Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications
⬇️
artículo científico publicado el 7 de septiembre de 2010
Assessment of mean platelet volume in coronary artery disease - what does it mean?
artículo científico publicado en 2006
Assessment of platelet activation indices using the ADVIATM120 amongst ‘high‐risk’ patients with hypertension
Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: the Gulf SAFE registry
artículo científico publicado en 2013
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
artículo científico publicado en 2015
Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation
artículo científico publicado en 2017
Association Between Digoxin Use and Adverse Outcomes Among Patients in the Chinese Atrial Fibrillation Registry
scientific article published on 01 December 2019
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation
artículo científico publicado en 2020
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
scientific article published on 01 July 2019
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients
artículo científico publicado en 2018
Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study
artículo científico publicado en 2020
Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage
scientific article published on 19 September 2020
Association between epicardial adipose tissue and embolic stroke after catheter ablation of atrial fibrillation
scientific article published on 19 September 2019
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial
Association between relative wall thickness of left ventricle and incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry
scientific article published on 16 January 2020
Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.
artículo científico publicado en 2015
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry
artículo científico publicado en 2019
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
artículo científico publicado en 2019
Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
artículo científico publicado en 2020
Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
scientific article published on 01 April 2020
Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
artículo científico publicado en 2016
Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)
artículo científico publicado en 2016
Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation
artículo científico publicado en 2020
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: a multicentre cohort study
⬇️
artículo científico publicado en 2020
Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage
scientific article published on 15 September 2020
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial
artículo científico publicado en 2014
Associations between socioeconomic status, atrial fibrillation and outcomes: A systematic review
article
Associations of Atrial Fibrillation Progression with Clinical Risk Factors and Clinical Prognosis: A report from the Chinese Atrial Fibrillation Registry Study
scientific article published on 02 December 2020
Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review
artículo científico publicado en 2016
Asymptomatic atrial fibrillation on device interrogation
artículo científico publicado en 2008
Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry
article by Giuseppe Boriani et al published May 2015 in American Journal of Medicine
Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect
artículo científico publicado en 2009
Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes
artículo científico
Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.
artículo científico publicado en 2012
Atherosclerotic renal artery stenosis--do we really know what to do?
artículo científico publicado en 2007
Atorvastatin and its collateral effects on microparticles
artículo científico publicado en 2011
Atrial Fibrillation
artículo científico publicado en 2012
Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke
artículo científico publicado en 2017
Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort
scientific article published on 14 November 2020
Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week
artículo científico publicado en 2019
Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention
artículo científico publicado en 2017
Atrial Fibrillation and End-Stage COPD: A Close Association Revisited
scientific article published on 01 May 2019
Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?
artículo científico publicado en 2016
Atrial Fibrillation and Hypertension
artículo científico publicado en 2017
Atrial Fibrillation and Stroke: Making Sense of Recent Observations on Anticoagulation
artículo científico publicado en 2016
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
artículo científico publicado en 2016
Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management
artículo científico publicado en 2020
Atrial Fibrillation in Older People: Concepts and Controversies
artículo científico publicado en 2019
Atrial Fibrillation in Patients With Hypertension: Trajectories of Risk Factors in Yet Another Manifestation of Hypertensive Target Organ Damage
artículo científico publicado en 2016
Atrial Fibrillation in the United Kingdom: Predicting Costs of an Emerging Epidemic Recognising and Forecasting the Cost Drivers of Atrial Fibrillation-related costs
artículo científico publicado en 2020
Atrial Fibrillation: Non Surgical Management
artículo científico publicado en 2010
Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators
artículo científico publicado en 2018
Atrial fibrillation
Atrial fibrillation
scientific article published on 11 December 2011
Atrial fibrillation
artículo científico publicado en 2014
Atrial fibrillation (acute onset)
scientific article published on 15 February 2011
Atrial fibrillation (acute onset)
scientific article published on 27 November 2014
Atrial fibrillation (acute onset).
artículo científico publicado en 2008
Atrial fibrillation (acute)
artículo científico publicado en 2003
Atrial fibrillation (acute)
artículo científico publicado en 2004
Atrial fibrillation (acute).
artículo científico publicado en 2003
Atrial fibrillation (chronic)
scientific article published on 10 November 2011
Atrial fibrillation (chronic)
Atrial fibrillation (chronic).
artículo científico publicado en 2008
Atrial fibrillation (recent onset).
artículo científico publicado en 2005
Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: a systematic literature review and case report
artículo científico publicado en 2020
Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes
artículo científico
Atrial fibrillation and heart failure: a bad combination
artículo científico publicado en 2014
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy
scientific article published on 11 January 2019
Atrial fibrillation and hypertrophic cardiomyopathy: co-existing conditions with additive risks
artículo científico publicado en 2017
Atrial fibrillation and its complications: a focus on identifying risk factors and risk stratification
artículo científico publicado en 2016
Atrial fibrillation and mortality: the impact of antithrombotic therapy
⬇️
artículo científico publicado el 4 de agosto de 2010
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care
Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye
artículo científico publicado en 2014
Atrial fibrillation and risk of stroke: a nationwide cohort study
artículo científico publicado en 2016
Atrial fibrillation and stroke prevention
artículo científico publicado en 2006
Atrial fibrillation and stroke prevention
artículo científico publicado en 2007
Atrial fibrillation and stroke prevention: brief observations on the last decade
artículo científico publicado en 2014
Atrial fibrillation and stroke risk prevention in real-life clinical practice
artículo científico publicado en 2009
Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice
artículo científico publicado en 2003
Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study
scientific article published on 01 February 2003
Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020
artículo científico publicado en 2020
Atrial fibrillation and thrombosis: the missing molecular links
artículo científico publicado en 2013
Atrial fibrillation and upper limb thromboembolectomy: a national cohort study
artículo científico publicado en 2011
Atrial fibrillation and vascular disease--a bad combination
artículo científico
Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review
artículo científico
Atrial fibrillation during sepsis: a determinant of long-term outcomes?
artículo científico publicado en 2014
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
artículo científico publicado en 2009
Atrial fibrillation in 2011: Stroke prevention in AF.
artículo científico publicado en 2011
Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation
artículo científico
Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
scientific article published on 24 January 2020
Atrial fibrillation in cryptogenic stroke: look harder, look longer, but just keep looking
artículo científico publicado en 2014
Atrial fibrillation in low- and middle-income countries: a narrative review
artículo científico publicado en 2020
Atrial fibrillation in obesity: Weighing up the evidence for catheter ablation
artículo científico publicado en 2020
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality
artículo científico publicado en 2018
Atrial fibrillation in primary aldosteronism.
artículo científico publicado en 2009
Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated
artículo científico publicado en 2018
Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly
artículo científico publicado en 2002
Atrial fibrillation is more frequently associated with non-obstructive coronary lesions: The Bialystok Coronary Project
artículo científico publicado en 2020
Atrial fibrillation occurring initially during acute medical illness: the heterogeneous nature of disease, outcomes and management strategies
article
Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
artículo científico publicado en 2018
Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".
artículo científico publicado en 2014
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation
artículo científico publicado en 2020
Atrial fibrillation post-cardiac surgery: changing perspectives.
artículo científico publicado en 2006
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management
artículo científico publicado en 2004
Atrial fibrillation …. more than simply being irregularly irregular
artículo científico publicado en 2014
Atrial fibrillation, arrhythmia burden and thrombogenesis
artículo científico publicado en 2011
Atrial fibrillation, the prothrombotic state, inflammation, and gender
artículo científico publicado en 2005
Atrial fibrillation--the growing epidemic
artículo científico publicado en 2007
Atrial fibrillation: Anticoagulation for AF: can we GRASP-AF patients?
artículo científico publicado en 2013
Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation
artículo científico publicado en 2010
Atrial fibrillation: Rate control and digoxin
artículo científico publicado en 2007
Atrial fibrillation: Stroke prevention in atrial fibrillation: can we do better?
artículo científico publicado en 2016
Atrial fibrillation: can it be as easy as CC to ABC?
scientific article published on 21 September 2020
Atrial fibrillation: current approaches to drug therapy
Atrial fibrillation: should we target platelets or the coagulation pathway?
artículo científico publicado en 2003
Atrial flutter and thromboembolic risk: a systematic review
artículo científico
Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes
artículo científico publicado en 2019
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices
artículo científico publicado en 2019
Atrial high-rate episodes and stroke prevention
artículo científico publicado en 2017
Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project
scientific article published on 17 April 2019
Author Response: Can Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes?
Authors' reply to Beales
artículo científico publicado en 2016
Autonomic function and rheumatoid arthritis: a systematic review
artículo científico publicado en 2014
Autonomic reflexes in heterotopic heart transplantation
artículo científico publicado en 2004
Avances incompletos en la estratificación del riesgo de ictus en la fibrilación auricular
artículo científico publicado en 2011
Avoiding Stroke: A Continuous Monitoring Challenge
scientific article published on 20 March 2020
Awareness and treatment of atrial fibrillation in older adults: the present and the future
artículo científico publicado en 2013
BLEEDING EVENTS AND THEIR CONSEQUENCES ON CARDIOVASCULAR EVENTS, READMISSION AND NET CLINICAL BENEFIT
artículo científico publicado en 2018
Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
artículo científico
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
artículo científico publicado en 2014
Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences
artículo científico publicado en 2017
Balancing thromboembolism and bleeding risks: insights from anticoagulation for prosthetic heart valves
artículo científico publicado en 2009
Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention
article
Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors
artículo científico publicado en 2007
Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension
artículo científico publicado en 2002
Baseline factors associated with early and late death in intracerebral haemorrhage survivors
artículo científico publicado en 2020
Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells
⬇️
artículo científico publicado el 1 de octubre de 2003
Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation.
artículo científico publicado en 2015
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial
artículo científico publicado en 2013
Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation
artículo científico
Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies
artículo científico publicado en 2011
Best practice for atrial fibrillation patient education
artículo científico
Beyond glucose levels in diabetic patients with coronary artery disease: platelet activity and non-responsiveness to antiplatelet therapy
scientific article published on 01 July 2008
Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?
artículo científico publicado en 2008
Biomarkers in atrial fibrillation: an overview
artículo científico
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect
artículo científico publicado en 2005
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes
artículo científico publicado en 2008
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
artículo científico publicado en 2009
Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy
artículo científico publicado en 2014
Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study.
artículo científico publicado en 2017
Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism
artículo científico publicado en 2017
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin
artículo científico publicado en 2015
Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?
scientific article published on 01 January 2010
Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation
artículo científico publicado en 2011
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vit
artículo científico
Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation
artículo científico publicado en 2014
Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
artículo científico publicado en 2009
Bleeding risk assessment and management in atrial fibrillation patients
article by Laurent Fauchier et al published 2011 in Thrombosis and Haemostasis
Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement
artículo científico publicado en 2012
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
scientific article published on May 2011
Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
artículo científico publicado en 2016
Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants
artículo científico publicado en 2013
Bleeding risk comparison between direct oral anticoagulants at doses approved for atrial fibrillation and aspirin: systematic review, meta-analysis and meta-regression
artículo científico publicado en 2020
Bleeding risk during oral anticoagulation therapy for atrial fibrillation
artículo científico publicado en 2013
Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
artículo científico publicado en 2011
Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
artículo científico publicado en 2011
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema
artículo científico publicado en 2006
Bleeding risk with oral anticoagulation - new frontiers and new questions
artículo científico publicado en 2011
Bleeding risks of antithrombotic therapy
artículo científico publicado en 2002
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
artículo científico publicado en 2008
Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.
artículo científico publicado en 2017
Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation
scientific article published on 16 March 2020
Blood Pressure Variability and Incidence of New-Onset Atrial Fibrillation: A Nationwide Population-Based Study
artículo científico publicado en 2019
Blood glucose reduction by diabetic drugs with minimal hypoglycaemia risk for cardiovascular outcomes: Evidence from meta-regression analysis of randomized controlled trials
artículo científico publicado en 2018
Blood leukocytes in heart failure with preserved ejection fraction: impact on prognosis
artículo científico publicado en 2012
Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias
artículo científico publicado en 2006
Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
artículo científico publicado en 2015
Blood pressure changes in acute haemorrhagic stroke
artículo científico publicado en 2005
Blood pressure control and prevention of stroke
artículo científico publicado en 2006
Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement?
artículo científico publicado en 2006
Blood pressure demographics: nature or nurture ... ... genes or environment?
artículo científico publicado en 2005
Blood pressure targets in atrial fibrillation
artículo científico publicado en 2020
Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study
scientific article published on 01 February 2019
Body Mass Index and Adverse Outcomes in Elderly Patients With Atrial Fibrillation: The AMADEUS Trial
artículo científico publicado en 2015
Body mass index and adverse events in patients with incident atrial fibrillation
artículo científico publicado en 2013
Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation
scientific article published on 01 October 2019
Breaking the rules for studies using real-world observational data: The case of direct-acting anticoagulants and antiepileptic drugs
artículo científico publicado en 2019
Breast density as a predictor of breast cancer risk
artículo científico publicado en 2010
Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation
artículo científico publicado en 2012
Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation
artículo científico publicado en 2012
Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study
artículo científico publicado en 2015
Bridging therapy: a challenging area in the management of patients with atrial fibrillation
artículo científico publicado en 2013
Brugada syndrome: A general cardiologist's perspective
artículo científico publicado en 2017
Burden of atrial fibrillation
artículo científico publicado en 2009
C-reactive protein and lone atrial fibrillation: potential confounders
artículo científico publicado en 2006
C0320 Oral anticoagulation in atrial fibrillation, the patients and physicians experiences of the consultation: A qualitative study
C0386 A meta-synthesis of qualitative studies exploring patients' and healthcare professionals views of atrial fibrillation and oral anticoagulant therapy
article
C0589: Relationship of the SAME-TT2R2 Score to Poor Quality Anticoagulation, Stroke, Clinically Relevant Bleeding and Mortality in Patients with Atrial Fibrillation
artículo científico publicado en 2014
C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study
scientific article published on 25 June 2019
C9orf72 and intracerebral hemorrhage
scientific article published on 18 July 2019
CAD Is an Independent Risk Factor for Stroke Among Patients With Atrial Fibrillation
artículo científico publicado en 2018
CD14++CD16+ monocytes in patients with acute ischaemic heart failure
artículo científico publicado en 2012
CD36 expression and lipid metabolism following an oral glucose challenge in South Asians
artículo científico publicado en 2015
CD4(+) T cell surface alpha enolase is lower in older adults.
artículo científico publicado en 2015
CHA 2 DS 2 -VASc Risk Scheme: Response
artículo científico publicado en 2010
CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm
artículo científico publicado en 2016
CHA2DS2-VASC SCORE AND ADVERSE EVENTS IN PATIENTS WITH HEART FAILURE AND SINUS RHYTHM
CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Kore
artículo científico publicado en 2017
CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
artículo científico publicado en 2017
CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis
artículo científico publicado en 2016
CHA2DS2-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?
scientific article published on 06 January 2017
CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention
artículo científico publicado en 2014
CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation
artículo científico publicado en 2013
CHOICES IN ANTITHROMBOTIC MANAGEMENT FOR PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. QUESTIONS (AND ANSWERS) IN CHRONOLOGICAL SEQUENCE
artículo científico publicado en 2020
CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY
artículo científico publicado en 2014
CLINICAL PORTRAIT OF THE ATRIAL FIBRILLATION PATIENT IN Russian FEDERATION. DATA FROM THE GLOBAL REGISTRY Gloria AF
artículo científico publicado en 2017
COGNITIVE FUNCTION IN AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE: INSIGHTS FROM THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL
artículo científico publicado en 2014
COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS
artículo científico publicado en 2019
COMPARISON OF EFFECTIVENESS, SAFETY, AND THE NET CLINICAL OUTCOME BETWEEN DIFFERENT DIRECT ORAL ANTICOAGULANTS IN 162,707 NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED IN US CLINICAL PRACTICE
artículo científico publicado en 2018
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
scientific article published on 15 April 2020
CXCR4 positive and angiogenic monocytes in myocardial infarction.
artículo científico publicado en 2012
Can Patients With Atrial Fibrillation Be Optimally Risk Stratified for Stroke and Thromboembolism?
artículo científico publicado en 2007
Can We IMPROVE Bleeding Risk Assessment for Acutely Ill, Hospitalized Medical Patients?
⬇️
artículo científico publicado el 1 de enero de 2011
Can the NICE guidelines on the management of atrial fibrillation improve its management?
artículo científico publicado en 2009
Can the WATCHMAN device truly PROTECT from stroke in atrial fibrillation?
artículo científico publicado en 2009
Can venous thromboembolism navigate the prevention of cardiovascular complications?
artículo científico publicado en 2015
Can we predict stroke in atrial fibrillation?
artículo científico
Cancer and atrial fibrillation. Author's reply
artículo científico publicado en 2019
Cancer and ethnic minorities
artículo científico publicado en 2002
Cancer and the prothrombotic state
artículo científico publicado en 2002
Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis
artículo científico publicado en 2018
Candidate circulating biomarkers for the cardiovascular disease continuum
artículo científico publicado en 2008
Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy
artículo científico publicado en 2016
Cardiac Electronic Devices: Future Directions and Challenges
artículo científico publicado en 2020
Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications
artículo científico publicado en 2015
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.
artículo científico publicado en 2014
Cardiac arrhythmias in patients with COVID-19
artículo científico publicado en 2020
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
artículo científico publicado en 2019
Cardiac biomarkers: myths, facts and future horizons
scientific article published on 01 November 2007
Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
artículo científico publicado en 2018
Cardiac rehabilitation meta-analysis of trials in patients with coronary heart disease using individual participant data (CaReMATCH): Project protocol
scientific article published on 02 September 2020
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Lat
artículo científico
Cardiomyopathy in practice
artículo científico publicado en 2002
Cardiovascular Events and Mortality in Patients With Atrial Fibrillation and Anemia (from the Fushimi AF Registry)
artículo científico publicado en 2020
Cardiovascular Risk Profiles amongst Women in a Multiethnic Population in Inner City Britain: A Potential Impact of Anaemia
artículo científico publicado en 2013
Cardiovascular autonomic regulation, inflammation and pain in rheumatoid arthritis
artículo científico publicado en 2017
Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults
artículo científico publicado en 2014
Cardiovascular risk prediction: balancing complexity against simple practicality
artículo científico publicado en 2015
Cardioversion and remodelling in atrial fibrillation: Insights beyond the prothrombotic state
scientific article published on 24 October 2007
Cardioversion and the endothelium in atrial fibrillation
scientific article published on 31 May 2005
Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey
artículo científico publicado en 2013
Cardioversion for atrial fibrillation: does inflammation matter?
artículo científico publicado en 2007
Cardioversion of atrial fibrillation
Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice
scientific article published on 01 May 2007
Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
artículo científico publicado en 2016
Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study
artículo científico publicado en 2017
CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension
scientific article published on 14 May 2019
Casebook: dyspnoea
artículo científico publicado el 1 de abril de 2003
Catheter ablation of atrial fibrillation and thromboembolic risk
artículo científico publicado en 2015
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
artículo científico publicado en 2016
Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry
artículo científico publicado en 2019
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
artículo científico publicado en 2018
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
artículo científico publicado en 2019
Cerebrovascular Dysfunction in Atrial Fibrillation
scientific article published on 09 September 2020
Cerebrovascular disease, associated risk factors and antithrombotic therapy in a population screening cohort: Insights from the Belgian Heart Rhythm Week programme
artículo científico publicado en 2016
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
artículo científico publicado en 2013
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
artículo científico publicado en 2017
Challenges facing anticoagulation among the elderly and frail
artículo científico publicado en 2009
Challenges in stroke prevention among very elderly patients with atrial fibrillation: discerning facts from prejudices
artículo científico publicado en 2020
Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation
artículo científico publicado en 2017
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer
artículo científico publicado en 2006
Changes in renal function after catheter ablation of atrial fibrillation are associated with CHADS2 and CHA2DS2-VASc scores and arrhythmia recurrences
artículo científico publicado en 2014
Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants
artículo científico publicado en 2018
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot gene
article
Changing the scope of preventative and therapeutic approaches in atherothrombosis
artículo científico publicado en 2010
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients
artículo científico publicado en 2010
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF
artículo científico publicado en 2020
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry
artículo científico publicado en 2020
Characterization of the proportion of untreated and antiplatelet therapy treated patients with atrial fibrillation
artículo científico publicado en 2011
Chemical cardioversion of atrial fibrillation with intravenous dofetilide
⬇️
artículo científico publicado el 1 de abril de 1995
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study.
artículo científico publicado en 2018
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation
artículo científico publicado en 2013
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
artículo científico publicado en 2016
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
artículo científico publicado en 2016
Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
artículo científico publicado en 2015
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
scientific article published on 19 April 2016
Chronic Osteomyelitis and Atrial Fibrillation: Revisiting the Link Between Inflammation Burden and Arrhythmia
artículo científico publicado en 2016
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm S
article
Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk
⬇️
artículo científico publicado el 7 de diciembre de 2010
Circulating Markers of Endothelial Function
Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease
artículo científico publicado en 2009
Circulating biomarkers of fibrosis and cardioversion of atrial fibrillation: A prospective, controlled cohort study
⬇️
artículo científico publicado en 2016
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index
artículo científico publicado en 2009
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction
scientific article published on 19 January 2009
Circulating endothelial cells in acute ischaemic stroke
artículo científico publicado en 2005
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease
artículo científico publicado en 2005
Circulating endothelial cells in cardiovascular disease
artículo científico publicado en 2006
Circulating endothelial cells in health and disease: how do we best quantify them?
artículo científico publicado en 2008
Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson
artículo científico publicado en 2007
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension
artículo científico publicado en 2007
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
artículo científico publicado en 2006
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes
scientific article published on 16 September 2004
Circulating endothelial cells. Biomarker of vascular disease
artículo científico publicado en 2005
Circulating endothelial cells: from bench to clinical practice
artículo científico publicado en 2008
Circulating endothelial cells: realities and promises in vascular disorders
artículo científico publicado en 2003
Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer
artículo científico publicado en 2004
Circulating levels of adiponectin, leptin, and tumour necrosis factor α in hypertension
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension
artículo científico publicado en 2005
Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?
scientific article published on June 2008
Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis
artículo científico publicado en 2010
Circulating microparticles: challenges and perspectives of flow cytometric assessment
artículo científico publicado en 2014
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity.
scientific article published on 21 June 2011
Circulating monocytes and atherogenesis: from animal experiments to human studies
artículo científico publicado en 2010
Circulating progenitor cells in patients with atrial fibrillation and their relation with serum markers of inflammation and angiogenesis
scientific article published on 27 May 2010
Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function
artículo científico publicado en 2008
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis
artículo científico publicado en 2018
Clinical Characteristics and Outcomes in Extreme Elderly (Age ≥ 85 Years) Japanese Patients With Atrial Fibrillation: The Fushimi AF Registry
artículo científico publicado en 2015
Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
artículo científico publicado en 2017
Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry
artículo científico publicado en 2017
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure – Subanalysis of the WARCEF Trial –
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients
artículo científico publicado en 2015
Clinical and basic science articles from Thrombosis and Haemostasis
artículo científico publicado en 2011
Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry.
artículo científico publicado en 2018
Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association
artículo científico publicado en 2019
Clinical factors and imaging leading to risk of incident atrial fibrillation
artículo científico publicado en 2019
Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial
artículo científico publicado en 2020
Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulants
artículo científico publicado en 2017
Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial
artículo científico publicado en 2020
Clinical outcomes of acute stroke patients with atrial fibrillation
artículo científico publicado en 2009
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control
artículo científico publicado en 2004
Clinical risk factors and subclinical target organ damage as predictors of new-onset of atrial fibrillation: the Catanzaro atrial fibrillation project
artículo científico publicado en 2014
Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review
artículo científico publicado en 2017
Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation
scientific article published on 14 January 2019
Coagulopathic complications in breast cancer
artículo científico publicado en 2003
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF
artículo científico publicado en 2019
Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations
artículo científico publicado en 2020
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy
artículo científico publicado en 2017
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial
artículo científico publicado en 2014
Cohort profile The ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry
artículo científico publicado en 2020
Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients
artículo científico publicado en 2009
Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?
artículo científico
Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?
scientific article published on 17 January 2011
Combining Anticoagulant and Antiplatelet Therapies for Chronic Atherosclerotic Disease: A Focus on Diabetes Mellitus as a High-Risk Patient Group
artículo científico publicado en 2020
Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited
artículo científico publicado en 2007
Comentarios al análisis crítico de la Sociedad Española de Cardiología de la guía de práctica clínica de fibrilación auricular 2010 de la ESC
artículo científico publicado en 2012
Commencing 2011 with Thrombosis and Haemostasis – and looking to the future
Commentary
artículo científico publicado en 2004
Comments on the Spanish Society of Cardiology critical review of the ESC 2010 clinical practice guidelines on atrial fibrillation
artículo científico publicado en 2012
Common Clinical Indications for Anticoagulation
artículo científico publicado en 2013
Common Questions in Anticoagulation Management in Atrial Fibrillation
artículo científico publicado en 2014
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes
artículo científico publicado en 2007
Community screening for atrial fibrillation in the era of smart devices
artículo científico publicado en 2019
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
scientific article published on 10 September 2020
Comparative Analysis of the HAS-BLED Score With Other Bleeding Risk Scores, Using Estimates of Net Reclassification Improvement and Integrated Discrimination Improvement
artículo científico publicado en 2011
Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study
artículo científico publicado en 2012
Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.
artículo científico publicado en 2013
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure
artículo científico publicado en 2007
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
scientific article published on 16 June 2016
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes
artículo científico publicado en 2015
Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation
artículo científico publicado en 2015
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly
artículo científico publicado en 2010
Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation
artículo científico publicado en 2017
Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial
artículo científico publicado en 2020
Comparing the 'new' R2CHADS2 with the 'old' CHA2DS2-VASc scores for predicting thromboembolism in patients undergoing atrial fibrillation ablation: new does not mean better
artículo científico publicado en 2013
Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study
artículo científico publicado en 2019
Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis
artículo científico publicado en 2017
Comparison of Dabigatran Plus a P2Y12 Inhibitor with Warfarin-Based Triple Therapy across Body Mass Index in RE-DUAL PCI
scientific article published on 07 May 2020
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation
article
Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis.
artículo científico publicado en 2017
Comparison of Risk Scores for the Prediction of the Overall Cardiovascular Risk in Patients with Ischemic Stroke: The Athens Stroke Registry
scientific article published on 25 October 2019
Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects
artículo científico publicado en 2005
Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation
artículo científico publicado en 2013
Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation
artículo científico publicado en 2014
Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries
artículo científico publicado en 2012
Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project).
artículo científico publicado en 2004
Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials
artículo científico publicado en 2010
Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients
scientific article published on 16 March 2018
Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial
scientific article published on 19 September 2013
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After
scientific article published on 09 December 2019
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
scientific article published on 21 May 2019
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure
artículo científico publicado en 2010
Compliance and the treatment of hypertension: where are we now?
artículo científico publicado en 2007
Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry
scientific article published on 29 April 2020
Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry
artículo científico publicado en 2020
Compliance with pharmacological therapy in hypertension: can we do better, and how?
scientific article published on 01 September 2004
Composite end point analyses of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
artículo científico
Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation
artículo científico publicado en 2014
Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial
scientific article published on 06 May 2020
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options
article
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
artículo científico publicado en 2011
Congestive heart failure and Virchow's triad: a neglected association
artículo científico publicado en 2003
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
artículo científico publicado en 2008
Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus
artículo científico publicado en 2017
Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation
scientific article published on 01 April 2020
Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding
artículo científico publicado en 2019
Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?
artículo científico publicado en 2014
Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study
artículo científico publicado en 2014
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry
Continuous retinal vessel diameter measurements: the future in retinal vessel assessment?
artículo científico publicado en 2010
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
artículo científico publicado en 2009
Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
scientific article published on 24 June 2019
Conventional and new oral anticoagulants in the treatment of chest disease and its complications
scientific article published on 01 August 2013
Coronary artery disease and ischemic stroke in atrial fibrillation
artículo científico publicado en 2007
Coronary artery disease and risk of adverse cardiac events and stroke
artículo científico publicado en 2017
Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation
artículo científico publicado en 2013
Coronary atherosclerosis in rheumatoid arthritis: could endothelial progenitor cells be the missing link?
artículo científico publicado en 2010
Coronary heart disease and atrial fibrillation
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
artículo científico publicado en 2007
Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options
Correction to: Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry
artículo científico publicado en 2018
Correction: Blood pressure measurement in atrial fibrillation: goodbye mercury?
artículo científico publicado en 2020
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation
artículo científico publicado en 2005
Corrigendum to "Dabigatran in clinical practice: Contemporary overview of the evidence" [Int. J. Cardiol. 220 (2016) 417-428].
artículo científico publicado en 2016
Corrigendum to: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’[Eur Heart J 2012;33:1787–1847, doi:10.1093/eurheartj/ehs104
scholarly article published in European Heart Journal
Corrigendum to: ‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747]
scholarly article published in EP Europace
Corrigendum to: ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’ [Eur J Heart Fail 2012;14: 803-869]
scholarly article published in European Journal of Heart Failure
Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420]
scholarly article published in European Heart Journal
Corrigendum to: ‘The adhesion molecule P-selectin and cardiovascular disease’ [Eur Heart J 2003;24:2166–2179]
artículo científico publicado en 2006
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
artículo científico publicado en 2017
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)
scientific article published on 06 November 2018
Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants
artículo científico publicado en 2013
Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation
artículo científico publicado en 2011
Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses
artículo científico publicado en 2016
Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme
artículo científico publicado en 2019
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
artículo científico publicado en 2015
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke
artículo científico publicado en 2016
Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany
artículo científico publicado en 2015
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation
artículo científico publicado en 2014
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
artículo científico publicado en 2014
Cross-cultural adaptation into Punjabi of the English version of the Hospital Anxiety and Depression Scale
artículo científico publicado en 2007
Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study
artículo científico
Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry
artículo científico publicado en 2018
Current Understanding of Atherogenesis
artículo científico publicado en 2016
Current and emerging drug treatment strategies for peripheral arterial disease
scientific article published on 19 June 2020
Current anticoagulation therapy--a GP guide.
artículo científico publicado en 2004
Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey.
artículo científico publicado en 2013
Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey
artículo científico publicado en 2013
Current practice in out-of-hospital cardiac arrest management: a european heart rhythm association EP network survey
Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey
artículo científico publicado en 2013
Current therapeutic strategies and future perspectives for the prevention of arterial thromboembolism: focus on atrial fibrillation
scientific article published on January 2010
D-Dimer elevation and adverse outcomes
artículo científico publicado en 2015
D-dimer tests for assessment of patients with suspected pulmonary embolism
scientific article published on 01 January 2003
DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI
artículo científico publicado en 2018
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation
artículo científico publicado en 2020
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes
scientific article published on 01 December 2019
Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range
scientific article published on 01 November 2019
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial
artículo científico publicado en 2020
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry
artículo científico publicado en 2019
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study.
artículo científico publicado en 2015
Dabigatran and myocardial infarction
artículo científico publicado en 2015
Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study
scientific article published on 01 September 2014
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation
artículo científico publicado en 2010
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
scholarly article by Jonas Oldgren et al published 14 May 2019 in European Heart Journal
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice
artículo científico publicado en 2012
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance
scientific article published on 14 June 2012
Dabigatran etexilate for venous thromboembolism: a safety evaluation
artículo científico
Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?
artículo científico publicado en 2012
Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk
artículo científico publicado en 2010
Dabigatran in clinical practice: Contemporary overview of the evidence
artículo científico publicado en 2016
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
artículo científico publicado en 2013
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study
artículo científico
Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
artículo científico publicado en 2018
Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
artículo científico publicado en 2019
Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2016
Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers
artículo científico publicado en 2006
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor
scientific article published on 08 December 2016
Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami
artículo científico publicado en 2017
Defibrillation testing in patients with atrial fibrillation
scientific article published on 23 June 2009
Defibrillators for prevention from sudden cardiac death: is it that easy?-Authors' reply
scientific article published on 01 April 2020
Dementia and Atrial Fibrillation: A Dangerous Combination for Ischemic Stroke and Mortality
artículo científico publicado en 2018
Depression, anxiety, and quality of life in patients with atrial fibrillation
artículo científico publicado en 2007
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fi
artículo científico publicado en 2016
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
artículo científico publicado en 2013
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison
artículo científico publicado en 2006
Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways
artículo científico publicado en 2020
Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population
artículo científico publicado en 2016
Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
artículo científico publicado en 2016
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis
scientific article published on 01 November 2019
Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study
scientific article published on 20 February 2020
Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.
artículo científico publicado en 2015
Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs
artículo científico publicado en 2012
Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation
artículo científico publicado en 2012
Development and validation of a new assay for assessing clot integrity
artículo científico publicado en 2015
Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study
artículo científico publicado en 2013
Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preference
artículo científico publicado en 2015
Device-Pocket Hematoma after Cardiac Implantable Electronic Devices
scientific article published on 20 March 2020
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Socied
artículo científico publicado en 2017
Diabetes Health, Residence & Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial
artículo científico publicado en 2011
Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.
artículo científico publicado en 2005
Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation
artículo científico publicado en 2016
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart
artículo científico publicado en 2004
Diabetes, the renin-angiotensin system and heart disease
artículo científico publicado en 2003
Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
scientific article published on 20 January 2020
Diastolic heart failure: recognition, diagnosis and management
artículo científico publicado en 2004
Differences between ACC/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes
scientific article published on 07 June 2013
Differences between South Asians and White Europeans in five year outcome following percutaneous coronary intervention
artículo científico publicado en 2011
Differences between indirect comparison studies of the oral anticoagulants for stroke prevention in atrial fibrillation: where do we go next?
artículo científico publicado en 2012
Differences in Heart Rate Response and Recovery After 6-Minute Walk Test Between Patients With Atrial Fibrillation and in Sinus Rhythm
artículo científico publicado en 2018
Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study)
artículo científico publicado en 2020
Differences in outcomes between oral anticoagulation "new starters" and "switchers" in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials
scientific article published on 11 November 2019
Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.
artículo científico publicado en 2005
Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice
article by Giuseppe Boriani et al published September 2015 in EP Europace
Difficult situations in anticoagulation after stroke: between Scylla and Charybdis
artículo científico publicado en 2015
Dipyridamole
scientific article published on 01 May 1992
Direct Oral Anticoagulants in Atrial Fibrillation Patients with Concomitant Hyperthyroidism
artículo científico publicado en 2020
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
scientific article published on 01 March 2019
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
scientific article published on 01 July 2019
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
artículo científico publicado en 2018
Direct oral anticoagulant reversal: how, when and issues faced
artículo científico publicado en 2017
Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
artículo científico publicado en 2018
Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study
artículo científico publicado en 2018
Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?
scientific article published on 24 January 2013
Do protein Z levels influence the prothrombotic state in atrial fibrillation?
artículo científico publicado en 2002
Do the National Institute of Clinical Excellence guidelines apply to 'real world' use of Abciximab in percutaneous coronary intervention in a teaching hospital setting?
artículo científico publicado en 2006
Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
artículo científico publicado en 2012
Documenting Sex and Sex Differences in Animal Studies
scientific article published on 05 May 2020
Does ECG have additive benefit for predicting atrial fibrillation in patients with or without hypertension?
artículo científico publicado en 2018
Does Renal Function Predict Short- and Medium-Term Mortality and Hospital Readmissions in Poststroke Patients?
artículo científico publicado en 2018
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
artículo científico publicado en 2013
Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project
artículo científico publicado en 2013
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation
artículo científico
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?
artículo científico publicado en 2006
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
artículo científico publicado en 2017
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
artículo científico publicado en 2010
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation
artículo científico publicado en 2008
Dronedarone (Multaq®) for the treatment of atrial fibrillation
artículo científico publicado en 2011
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice
scientific article published on 02 December 2010
Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study
⬇️
artículo científico publicado el 1 de diciembre de 2010
Dronedarone: NICE enough?
⬇️
artículo científico publicado el 1 de agosto de 2010
Dronedarone: a new hope for stroke prevention in atrial fibrillation?
artículo científico publicado en 2011
Dronedarone: an overview
artículo científico publicado en 2011
Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension
artículo científico publicado en 2004
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.
artículo científico publicado en 2007
Drug-drug interactions of non-vitamin K oral anticoagulants
artículo científico publicado en 2016
Drug-eluting stents: a comprehensive appraisal
scientific article published on March 2009
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
artículo científico publicado en 2007
Drug-induced liver injury with oral anticoagulants: a threat or not?
artículo científico publicado en 2017
Drugs for atrial fibrillation.
artículo científico publicado en 1996
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
artículo científico publicado en 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
artículo científico publicado en 2018
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST elevation myocardial infarction: results from the randomised RE-DUAL PCI trial
artículo científico publicado en 2020
Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block
artículo científico publicado en 2004
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study
artículo científico publicado en 2015
Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study
article
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation
artículo científico publicado en 2016
EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY
EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS
artículo científico publicado en 2019
EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED TO WARFARIN AMONG FRAIL NONVALVULAR ATRIAL FIBRILLATION PATIENTS
artículo científico publicado en 2019
EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN OBESE NONVALVULAR ATRIAL FIBRILLATION PATIENTS: A POOLED CLAIMS DATABASE ANALYSIS
artículo científico publicado en 2019
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019
article by Andreas Goette et al published 1 July 2019 in EP Europace
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
scientific article published on 01 January 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update
artículo científico publicado en 2019
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
artículo científico
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.
artículo científico publicado en 2016
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.
artículo científico publicado en 2016
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.
artículo científico publicado en 2016
ESC Council on hypertension position document on the management of hypertensive emergencies
scientific article published on 01 January 2019
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the
artículo científico publicado en 2012
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE?
artículo científico publicado en 2015
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES
artículo científico publicado en 2014
EUR Observational research programme: atrial fibrillation general registry pilot phase.
artículo científico publicado en 2013
Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients
artículo científico publicado en 2022
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.
artículo científico publicado en 2009
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
artículo científico publicado en 2009
Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors.
artículo científico publicado en 2014
Early management of atrial fibrillation to prevent cardiovascular complications
artículo científico
Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.
artículo científico publicado en 2018
Echocardiographic Structure and Function in Hypertensive Disorders of Pregnancy: A Systematic Review
artículo científico publicado en 2016
Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands
artículo científico publicado en 2019
Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
artículo científico publicado en 2006
Editorial [Hot Topic: The Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
artículo científico publicado en 2007
Editorial commentary: Reversal agents in the era of non-vitamin k antagonists oral anticoagulants: Necessity or psychological crutch?
scientific article published on 27 April 2019
Editors choice: recent highlights from the journal of human hypertension
artículo científico publicado en 2010
Editors' Choice 2016 papers in Thrombosis and Haemostasis.
artículo científico publicado en 2017
Editors' Choice in the 60th Anniversary Year of Thrombosis and Haemostasis: Past, Present and Future
artículo científico publicado en 2018
Editors' Choice papers in Thrombosis and Haemostasis
artículo científico publicado en 2015
Editors’ Choice 2015 papers in Thrombosis and Haemostasis
artículo científico publicado en 2016
Editors’ Choice papers in Thrombosis and Haemostasis
Editor´s choice articles 2008–2009
artículo científico publicado en 2010
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation
artículo científico publicado en 2015
Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study
artículo científico publicado en 2017
Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety
scientific article published on 01 August 2018
Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody
artículo científico publicado en 2012
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons
artículo científico publicado en 2014
Edoxaban in venous thromboembolism and stroke prevention: an appraisal
artículo científico publicado en 2016
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study
artículo científico publicado en 2018
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
artículo científico publicado en 2016
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis
artículo científico publicado en 2015
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
artículo científico publicado en 2020
Edoxaban: a focused review of its clinical pharmacology
artículo científico
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
artículo científico publicado en 2010
Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial
artículo científico publicado en 2013
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
artículo científico publicado en 2015
Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study
artículo científico publicado en 2016
Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction
artículo científico publicado en 2020
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial
artículo científico publicado en 2020
Effect of Implantable Cardioverter-Defibrillators by Etiology of Heart Failure: A Propensity-Matched Mortality Analysis of the WARCEF Trial
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
artículo científico publicado en 2021
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial
scientific article published on 07 April 2020
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
artículo científico publicado en 2018
Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients
artículo científico publicado en 2017
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
artículo científico publicado en 2018
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
artículo científico publicado en 2016
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial
scientific article published on 31 March 2020
Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population
artículo científico publicado en 2019
Effect of hypertension on anticoagulated patients with atrial fibrillation
scientific article published on 08 February 2007
Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin
artículo científico publicado en 2016
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA
artículo científico publicado en 2019
Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer
artículo científico publicado en 2014
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study
artículo científico publicado en 2016
Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation
artículo científico publicado en 2019
Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
artículo científico publicado en 2019
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use
artículo científico publicado en 2020
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis
artículo científico publicado en 2020
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asians with Non-valvular Atrial Fibrillation
article
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation
artículo científico publicado en 2017
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study
artículo científico publicado en 2018
Effectiveness and Safety of Oral Anticoagulants Among Non-Valvular Atrial FibrillationPatients with Polypharmacy
scientific article published on 03 October 2020
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
article by Gregory Lip et al published December 2018 in Stroke Journal
Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study
artículo científico publicado en 2020
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus
scientific article published on 01 May 2020
Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.
artículo científico publicado en 2017
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients
artículo científico publicado en 2017
Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish nationwide cohort
scientific article published on 27 November 2019
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis
artículo científico publicado en 2017
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
artículo científico publicado en 2017
Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
artículo científico publicado en 2017
Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
artículo científico publicado en 2020
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial
artículo científico publicado en 2007
Effects of Aspirin on Endothelial Function and Hypertension
artículo científico publicado en 2016
Effects of Atrial Fibrillation and Chronic Kidney Disease on Major Adverse Cardiovascular Events
scientific article published on 11 July 2020
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State
artículo científico publicado en 2014
Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells
artículo científico publicado en 2003
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
artículo científico publicado en 2016
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2
artículo científico publicado en 2005
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm
artículo científico publicado en 2005
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients
artículo científico publicado en 2006
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease
artículo científico publicado en 2008
Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus
artículo científico publicado en 2009
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation
artículo científico publicado en 2006
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials
artículo científico publicado en 2014
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation
artículo científico publicado en 2005
Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus
artículo científico publicado en 2009
Effects of dietary fat intake in sudden death: reduction of death with omega-3 fatty acids
artículo científico publicado en 2004
Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review
artículo científico publicado en 2003
Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension
artículo científico publicado en 2004
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease
scientific article published on 13 January 2007
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis
artículo científico publicado en 2017
Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation
artículo científico publicado en 2016
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction
artículo científico publicado en 2006
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction
artículo científico publicado en 2005
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials
artículo científico publicado en 2016
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction
artículo científico publicado en 2007
Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation
artículo científico publicado en 2014
Effects of short-term glucocorticoids on cardiovascular biomarkers
artículo científico publicado en 2005
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers
artículo científico publicado en 2005
Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials.
artículo científico publicado en 2017
Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure
artículo científico publicado en 2007
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis
artículo científico publicado en 2017
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism
artículo científico publicado en 2019
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis
artículo científico publicado en 2019
Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials
artículo científico publicado en 2019
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
artículo científico publicado en 2013
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project.
artículo científico publicado en 2016
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation
artículo científico publicado en 2009
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis
artículo científico publicado en 2014
Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation – meta-analysis
artículo científico publicado en 2014
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
artículo científico publicado en 2002
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
artículo científico publicado en 2012
Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis
artículo científico publicado en 2017
Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.
artículo científico publicado en 2014
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
artículo científico publicado en 2016
Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation.
artículo científico
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
artículo científico publicado en 2014
Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
artículo científico publicado en 2012
Elevated angiogenin levels in chronic heart failure
artículo científico publicado en 2008
Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation
scientific article published on 02 December 2018
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy
artículo científico publicado en 2007
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation
artículo científico publicado en 2005
Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?
artículo científico publicado en 2016
Embolic stroke of undetermined source: The need for an integrated and holistic approach to care
scientific article published on 11 December 2020
Emerging Tools for Stroke Prevention in Atrial Fibrillation
artículo científico publicado en 2016
End-Stage renal disease and 30-day mortality for adults with and without COVID-19
artículo científico publicado en 2020
Endothelial (dys)function in lone atrial fibrillation
artículo científico publicado en 2015
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
artículo científico publicado en 2016
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes
artículo científico publicado en 2006
Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers?
artículo científico publicado en 2007
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management
artículo científico publicado en 2003
Endothelial damage/dysfunction and hypertension in pregnancy
artículo científico publicado en 2011
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide
scientific article published on 13 September 2004
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor
scientific article published on 09 January 2011
Endothelial dysfunction: methods of assessment & implications for cardiovascular diseases
artículo científico publicado en 2010
Endothelial dysfunction: methods of assessment and application to hypertension
artículo científico publicado en 2004
Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?
scientific article published on 01 August 2009
Endothelial function and its assessment
artículo científico publicado en 2005
Endothelial function in patients with atrial fibrillation
artículo científico publicado en 2020
Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers
artículo científico publicado en 2010
Endothelial progenitor cells in cardiovascular disorders
artículo científico publicado en 2007
Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X
artículo científico publicado en 2007
Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension
artículo científico publicado en 2008
Endothelial progenitor cells: from pathophysiology to clinical practice
artículo científico publicado en 2008
Endothelial progenitor cells: what use for the cardiologist?
artículo científico publicado en 2010
Endothelin binding and calcium signalling in hypertension
artículo científico publicado en 2002
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?
scientific article published on 23 June 2008
Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease
⬇️
artículo científico publicado el 15 de diciembre de 2010
Endotoxemia as a trigger of thrombosis in cirrhosis
artículo científico publicado en 2016
Endotoxemia, inflammation, and atrial fibrillation
artículo científico publicado en 2007
Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers.
artículo científico publicado en 2017
Eosinophil count predicts mortality following percutaneous coronary intervention
artículo científico publicado en 2012
Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles
artículo científico publicado en 2016
Epidemiology of atrial fibrillation
artículo científico publicado en 2018
Erectile dysfunction in atrial fibrillation: A risk factor for stroke or a reflection of stroke risk factors?
artículo científico publicado en 2015
Erratum to “Angiogenin, a marker of Angiogenesis increases with coronary heart disease severity” [Antheroscler. Suppl. 9 (May (1)) (2008) 247–248]
artículo científico publicado en 2011
Erratum to “Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias” [International Journal of Cardiology 107/1 (2006) 134–135]
scholarly article published in International Journal of Cardiology
Erratum: Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review
artículo científico publicado en 2017
Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients With Preserved Ejection Fraction: Evidence From the TOPCAT trial
scientific article published in 2022
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation
scientific article published on 02 June 2018
Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients
artículo científico publicado en 2017
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin
artículo científico publicado en 2013
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals
scientific article published on 25 September 2019
Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation
artículo científico publicado en 2015
Estimating individual lifetime benefit and bleeding risk of adding oral anticoagulation to aspirin for patients with stable cardiovascular disease: directions from COMPASS?
scientific article published on 01 December 2019
Ethnic differences in aortic aneurysm and peripheral vascular disease
artículo científico publicado en 1996
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke
scientific article published on 01 November 2005
Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening Project
artículo científico publicado en 2007
Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project
artículo científico publicado en 2005
Ethnic differences in common carotid intima-media thickness, and the relationship to cardiovascular risk factors and peripheral arterial disease: the Ethnic-Echocardiographic Heart of England Screening Study
⬇️
artículo científico publicado el 18 de octubre de 2010
Ethnic differences in left ventricular size and the prevalence of left ventricular hypertrophy among hypertensive patients vary with electrocardiographic criteria
artículo científico publicado en 2004
Ethnic differences in macrovascular and microvascular function in systolic heart failure
artículo científico publicado en 2011
Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus
artículo científico publicado en 2008
Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project
artículo científico publicado en 2002
Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project
artículo científico publicado en 2004
Ethnic differences in peripheral vascular disease
artículo científico publicado en 2002
Ethnic differences in the diurnal variation of symptom onset time for acute ST elevation myocardial infarction - An observational cohort study
artículo científico publicado en 2015
Ethnic differences in the prevalence of peripheral arterial disease: a systematic review and meta-analysis
artículo científico publicado en 2017
Ethnic disparities in malignant hypertension: further observations
artículo científico publicado en 2007
Ethnic/racial differences in circulating markers of angiogenesis and their association with cardiovascular risk factors and cardiovascular disease
artículo científico publicado en 2012
Ethnicity and arrhythmias
artículo científico publicado en 2003
Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management
artículo científico publicado en 2007
Ethnicity and peripheral artery disease
artículo científico publicado en 2008
Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project).
artículo científico publicado en 2003
Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines
artículo científico publicado en 2020
Etiologic workup in cases of cryptogenic stroke: protocol for a systematic review and comparison of international clinical practice guidelines
scientific article published on 17 December 2019
Etiological Research Using Observational Data, and Net Clinical Benefit. Simplicity and Practicality Matter
artículo científico publicado en 2019
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS)
artículo científico publicado en 2019
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y
artículo científico publicado en 2016
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y
artículo científico publicado en 2018
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
artículo científico publicado en 2018
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Socie
artículo científico publicado en 2016
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Societ
article
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?
artículo científico publicado en 2018
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
artículo científico publicado en 2018
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?
scientific article published on 18 March 2018
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right ou
artículo científico publicado en 2020
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right ou
scientific article published on 13 June 2020
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right out
artículo científico publicado en 2020
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
artículo científico publicado en 2015
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
artículo científico
Evaluating adherence to non-vitamin-K antagonist oral anticoagulants in post-approval observational studies of patients with atrial fibrillation.
artículo científico publicado en 2017
Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting
artículo científico publicado en 2016
Evaluation of a 'color coding' system for the assessment of patients undergoing primary percutaneous coronary intervention
artículo científico publicado en 2016
Evaluation of carotid plaque neovascularization using contrast ultrasound.
artículo científico publicado en 2012
Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
artículo científico publicado en 2012
Evaluation of the C2HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study)
scientific article published on 10 October 2019
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
artículo científico publicado en 2015
Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies
artículo científico publicado en 2015
Evidence guided antiplatelet treatment: time to move from bench to bedside.
artículo científico publicado en 2009
Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan
artículo científico publicado en 2018
Excessive Supraventricular Ectopic Activity and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis
artículo científico publicado en 2020
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulació
artículo científico publicado en 2016
Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?
artículo científico publicado en 2005
Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease
artículo científico
Experiences of living with congestive heart failure: a qualitative study.
artículo científico publicado en 2008
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
artículo científico publicado en 2013
Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation
artículo científico publicado en 2015
Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis.
artículo científico publicado en 2014
External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest
artículo científico publicado en 2017
Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension?
artículo científico publicado en 2003
Face to face with basic and clinical research in Thrombosis and Haemostasis
artículo científico publicado en 2009
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk
artículo científico publicado en 2008
Factor X inhibitors
⬇️
artículo científico publicado el 1 de mayo de 2003
Factor XI inhibition fulfilling the optimal expectations for ideal anticoagulation
artículo científico publicado en 2019
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
artículo científico publicado en 2004
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score
artículo científico publicado en 2013
Failed reperfusion with thrombolysis--the effect of a local environment?
artículo científico publicado en 2005
Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study
artículo científico publicado en 2020
Fast straining CT in assesment of difficult abdominal wall herniae
scientific article published on 01 February 2010
Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes
artículo científico publicado en 2020
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
artículo científico publicado en 2018
Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study
article
Female Sex, Time in Therapeutic Range, and Clinical Outcomes in Atrial Fibrillation Patients Taking Warfarin
artículo científico publicado en 2016
Female gender and atrial fibrillation: An association with worse prognosis and outcomes
artículo científico publicado en 2015
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients
artículo científico publicado en 2009
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2012
Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study
artículo científico publicado en 2014
Female sex is associated with a lower risk of stroke in patients with heart failure
artículo científico publicado en 2014
Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation
artículo científico publicado en 2006
Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus?
scientific article published on 01 July 2003
Fibrinolytic function and atrial fibrillation
artículo científico publicado en 2003
Fibrinolytic status in acute coronary syndromes: Evidence of differences in relation to clinical features and pathophysiological pathways
scientific article published on 27 April 2012
Finding atrial fibrillation: just keep looking, just keep looking … (but remember stroke prevention)
artículo científico publicado en 2013
Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice.
artículo científico publicado en 2018
Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study
artículo científico publicado en 2019
Fondaparinux
scientific article published on 01 January 2005
Fondaparinux in atrial fibrillation – old dog, new tricks?
artículo científico publicado en 2015
Fondaparinux: an overview.
artículo científico publicado en 2009
Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation
scientific article published on 31 October 2018
Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association
artículo científico publicado en 2018
Free Light Chains in patients with acute coronary syndromes: Relationships to inflammation and renal function
artículo científico publicado en 2015
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation
artículo científico publicado en 2015
From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants
artículo científico publicado en 2015
From diabetes to metabolic syndrome: a viewpoint on an evolving concept
artículo científico publicado en 2007
From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency
artículo científico publicado en 2015
From the CHA<sub>2</sub>DS<sub>2</sub>-VASc score to inflammation: a path leading to frailty? An update of the PURE-Rhythm Trial
artículo científico publicado en 2020
Further insights into the prothrombotic state in mitral stenosis and atrial flutter
artículo científico publicado en 2004
Future Directions
artículo científico publicado en 2013
GW26-e2300 Gender differences in clinical characteristics and inpatient outcomes amongst 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Registry
artículo científico publicado en 2015
GW26-e2302 Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-analysis of randomized trials
artículo científico publicado en 2015
Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis
scientific article published on 09 January 2020
Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease
artículo científico publicado en 2019
Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World"
artículo científico publicado en 2017
Gastrointestinal haemorrhage in atrial fibrillation patients: impact of quality of anticoagulation control.
artículo científico publicado en 2015
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: the GLORIA-AF Registry Program.
artículo científico publicado en 2018
Gender and the response to blood pressure-lowering treatment
scientific article published on 13 October 2008
Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool
artículo científico publicado en 2015
Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study
artículo científico publicado en 2011
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
artículo científico publicado en 2013
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.
artículo científico publicado en 2009
Generating Hypotheses Is Great, but at Some Point We Just Need to Do the Trials and Get the Answers
scientific article published on 09 January 2020
Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk
artículo científico publicado en 2010
Genetic polymorphisms and thromoembolic risk in atrial fibrillation
artículo científico publicado en 2004
Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials
article
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials
artículo científico publicado en 2017
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
scientific article published on 28 July 2016
Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus
artículo científico publicado en 2019
Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project
artículo científico publicado en 2009
Goodbye mercury? Blood pressure measurement and its future
artículo científico publicado en 2005
Gregory Lip
artículo científico publicado en 2012
Growth hormone therapy and the heart
scientific article published on 23 February 2006
Guideline Implications of Prothrombotic State Assessment in Low-Risk Atrial Fibrillation Patients: Consistency With CHA2DS2-VASc and Support for CHADS-65
scientific article published on 08 March 2019
Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry.
artículo científico publicado en 2017
Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries
scientific article published on 06 November 2019
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
scientific article published on 01 June 2007
Guideline-adherent secondary prevention post-acute coronary syndromes: the importance of patient uptake and persistence
scientific article published on 01 July 2018
Guideline: ACP and AAFP recommend systolic BP targets based on history and risk level in adults ≥ 60 years of age
scientific article published on 01 April 2017
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding
artículo científico publicado en 2010
Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding
artículo científico publicado en 2010
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
artículo científico publicado en 2010
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
artículo científico publicado en 2010
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST
Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST
Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar
article
Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012
Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007
article
HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism
artículo científico publicado en 2016
Haemoconcentration and the hypercoagulable state associated with mental stress.
artículo científico publicado en 2005
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage
scientific article published on 10 January 2020
Health care facility type-related challenges in the management of stroke risk in patients with atrial fibrillation: practical implications
artículo científico publicado en 2018
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)
Heart Failure and Stroke
artículo científico publicado en 2018
Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis
artículo científico publicado en 2015
Heart failure in East Asia
artículo científico publicado en 2013
Heart failure in a multiethnic population in Kuala Lumpur, Malaysia
artículo científico publicado en 2003
Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation
artículo científico publicado en 2015
Heart failure--the importance of ethnicity
artículo científico publicado en 2004
Heart failure: treatment and ethnic origin
artículo científico publicado en 2003
Heart rate variability changes following catheter ablation for atrial fibrillation
artículo científico publicado en 2020
Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease
artículo científico publicado en 2004
Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system
artículo científico publicado en 2019
Heart rate variability in patients with atrial fibrillation and hypertension
Heart type fatty acid binding protein: An overlooked cardiac biomarker
artículo científico publicado en 2020
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients
artículo científico publicado en 2005
Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues
artículo científico publicado en 2013
Hemostatic cardiovascular risk factors, common carotid–intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic‐Echocardiographic Heart of England Screening (E‐ECHOES) Study
⬇️
artículo científico publicado el 1 de abril de 2011
Hemoxygenase-1 in cardiovascular disease
artículo científico publicado en 2008
Heparin Bridging vs. Uninterrupted Oral Anticoagulation in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting
artículo científico publicado en 2012
Heparin-Induced Thrombocytopenia: Response
artículo científico publicado en 2009
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management
artículo científico publicado en 2009
Heterotopic heart transplantation
scientific article published on 01 May 2005
Hibernating myocardium in heart failure
artículo científico publicado en 2005
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction
artículo científico publicado en 2005
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
artículo científico publicado en 2012
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal
artículo científico publicado en 2012
High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
artículo científico publicado en 2020
High-risk myocardial infarction patients appear to derive more mortality benefit from short door-to-balloon time than low-risk patients
artículo científico publicado en 2009
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis
artículo científico publicado en 2007
High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.
artículo científico publicado en 2013
Highlights and hot topics from 2011 in Thrombosis and Haemostasis
artículo científico publicado en 2012
Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS
artículo científico publicado en 2012
Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.
artículo científico publicado en 2005
Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised c
artículo científico publicado en 2007
Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]
artículo científico publicado en 2003
Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role
artículo científico publicado en 2003
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation
artículo científico publicado en 2003
Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial
artículo científico publicado en 2014
Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension
artículo científico publicado en 2005
Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter?
artículo científico publicado en 2004
Hormone replacement therapy and cardiovascular risk
artículo científico publicado en 2002
Hormone replacement use and cardiovascular function and structure in postmenopausal women
artículo científico publicado en 2005
Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UK.
artículo científico publicado en 2012
How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey
artículo científico publicado en 2012
How do we get better at identifying patients with atrial fibrillation who are at ‘truly low risk’ or ‘truly high risk’ of stroke?
⬇️
artículo científico publicado el 15 de noviembre de 2010
How early is early enough to prevent stroke in atrial fibrillation?
artículo científico publicado en 2012
How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis
artículo científico publicado en 2005
How safe is the antiarrhythmic drug therapy in atrial fibrillation?
artículo científico publicado en 2009
How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring
artículo científico publicado en 2016
How to REVISIT the increasing "real world" evidence for stroke prevention in non-valvular atrial fibrillation?
scientific article published on 04 November 2016
How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?
artículo científico publicado el 1 de septiembre de 2010
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes
artículo científico publicado en 2017
Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks
artículo científico publicado en 2017
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension
artículo científico
Hypertension and cardiac arrhythmias
artículo científico publicado en 2017
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoam
artículo científico publicado en 2017
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS),
artículo científico publicado en 2017
Hypertension and cardiovascular risk factors when treating cancer patients: underrecognised and undertreated
scientific article published on 12 August 2020
Hypertension and renal failure
scientific article published on 01 July 2002
Hypertension and the prothrombotic state
scientific article published on 01 May 2003
Hypertension in pregnancy: pathophysiology and management strategies
artículo científico publicado en 2007
Hypertension in the Context of Acute Myocardial Infarction and Percutaneous Coronary Interventions
Hypertension management in cardio-oncology
artículo científico publicado en 2020
Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke
artículo científico publicado en 2009
Hypertension to heart failure: new developmental strategies do not cross a clinical and therapeutic divide
artículo científico publicado en 2003
Hypertension, anti-hypertensive therapy and neoplasia
artículo científico publicado en 2007
Hypertension, left ventricular hypertrophy, and sudden death
artículo científico publicado en 2002
Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited
scientific article published on 01 February 2003
Hypertension, stroke and the impact of atrial fibrillation
scientific article published on 01 November 2008
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy
artículo científico publicado en 2007
Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study
artículo científico publicado en 2019
IMPACT OF ANEMIA ON CLINICAL OUTCOME IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AFCAS REGISTRY
artículo científico publicado en 2014
IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL
article
IMPACT OF L-CARNITINE ON PLASMA LIPOPROTEIN(A) CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
artículo científico publicado en 2016
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
scientific article published on 05 October 2016
IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS
artículo científico publicado en 2018
Ideal Blood Pressure in Patients With Atrial Fibrillation
scientific article published on 01 September 2018
Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients
scientific article published on 31 October 2019
Identification, diagnosis and assessment of atrial fibrillation
artículo científico publicado en 2006
Identifying AF patients at risk of stroke: can prothrombotic indices improve things?
artículo científico publicado en 2008
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort
artículo científico publicado en 2010
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort
scientific article published on 01 December 2011
Idiopathic orbital pseudotumour
artículo científico publicado en 2011
Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation
artículo científico publicado en 2009
Imaging of the unstable plaque
scientific article published on 22 January 2008
Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation
scientific article published on 10 February 2020
Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology
artículo científico publicado en 2011
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)
artículo científico publicado en 2018
Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials
artículo científico publicado en 2016
Impact of Liver Disease on Oral Anticoagulant Prescription and Major Adverse Events in Patients with Atrial Fibrillation
scientific article published on 04 March 2020
Impact of Mon2 monocyte-platelet aggregates in humancoronary artery disease
artículo científico publicado en 2018
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation
artículo científico publicado en 2018
Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure
artículo científico publicado en 2015
Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice
artículo científico publicado en 2015
Impact of aerobic fitness on cerebral blood flow and cerebral vascular responsiveness to CO2 in young and older men.
artículo científico publicado en 2016
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
artículo científico publicado en 2016
Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry
artículo científico publicado en 2014
Impact of atrial fibrillation in critically-ill patients admitted to a stepdown unit
artículo científico publicado en 2020
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting
artículo científico publicado en 2008
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry
artículo científico publicado en 2016
Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes
artículo científico publicado en 2011
Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: Insights from the BALKAN-AF survey
scientific article published on 23 July 2020
Impact of non-vitamin k antagonist oral anticoagulants on intracranial bleeding in Asian patients with non-valvular atrial fibrillation
artículo científico publicado en 2014
Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy
artículo científico publicado en 2011
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
artículo científico publicado en 2018
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
artículo científico publicado en 2016
Impact of symptom control on health-related quality of life in atrial fibrillation patients: the psychologist's viewpoint
artículo científico publicado en 2010
Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study
artículo científico publicado en 2011
Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study
artículo científico publicado en 2016
Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes
artículo científico publicado en 2020
Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation
scientific article published on 01 March 2019
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?: JACC Review Topic of the Week
artículo científico publicado en 2019
Impaired fasting glycaemia vs. impaired glucose tolerance: two sides of the same coin with implications for cardiovascular risk
artículo científico publicado en 2004
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels
artículo científico publicado en 2007
Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction
artículo científico publicado en 2009
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation
scientific article published on 01 October 2005
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule
artículo científico publicado en 2008
Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation
⬇️
artículo científico publicado el 29 de septiembre de 2010
Implications of the LIFE trial
⬇️
artículo científico publicado el 1 de mayo de 2003
Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process
scientific article published on 02 February 2019
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
artículo científico publicado en 2017
Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway
artículo científico publicado en 2018
Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study
scientific article published on 02 July 2019
Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry
artículo científico publicado en 2015
Improvement and Aggravation of Spontaneous Unruptured Vertebral Artery Dissection
artículo científico publicado en 2017
Improving stroke risk stratification in atrial fibrillation
scientific article published on June 2010
Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring
Improving survival of malignant hypertension patients over 40 years
artículo científico publicado en 2009
Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?
artículo científico publicado en 2011
Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project
article
In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs
scientific article published on 01 December 2019
In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling
scientific article published on 01 April 2020
In patients with no indication for anticoagulation after TAVR, rivaroxaban increased adverse events vs antiplatelets
artículo científico publicado en 2020
In patients with type 2 diabetes and high CV risk, liraglutide reduced a composite CV outcome at a median 3.8 y.
artículo científico publicado en 2016
In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation.
artículo científico publicado en 2018
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction
artículo científico publicado en 2002
Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation
artículo científico publicado en 2015
Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry
scientific article published on 09 March 2018
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis
artículo científico publicado en 2014
Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study
scientific article published on 21 April 2020
Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation: The Fushimi Atrial Fibrillation Registry
artículo científico
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
artículo científico publicado en 2018
Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors
artículo científico publicado en 2015
Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially 'Low-Risk' Patients
artículo científico publicado en 2019
Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis
scientific article published on 24 April 2020
Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
artículo científico publicado en 2018
Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors
artículo científico publicado en 2018
Increased Stroke Risk in Atrial Fibrillation Patients With Heart Failure
artículo científico publicado en 2015
Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin
artículo científico publicado en 2005
Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure
artículo científico publicado en 2013
Increased formation of monocyte-platelet aggregates in ischemic heart failure
artículo científico publicado en 2012
Increased levels of plasma haemoxygenase-1 in prostate cancer
⬇️
artículo científico publicado el 25 de enero de 2011
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting
artículo científico publicado en 2008
Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.
artículo científico publicado en 2015
Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis
artículo científico publicado en 2016
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark
artículo científico publicado en 2017
Increases in lipids and immune cells in response to exercise and mental stress in patients with suspected coronary artery disease: effects of adjustment for shifts in plasma volume
artículo científico publicado en 2004
Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015
artículo científico publicado en 2018
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM)
artículo científico publicado en 2005
Indications for the use of diagnostic implantable and external ECG loop recorders
artículo científico publicado en 2009
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: Differences in central versus peripheral levels
article
Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease.
artículo científico publicado en 2003
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
artículo científico publicado en 2012
Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man.
artículo científico publicado en 1998
Inflammation and atrial fibrillation: cause or effect?
scientific article published on 01 February 2008
Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment
artículo científico publicado en 2010
Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
artículo científico publicado en 2018
Inflammation does not influence arterial stiffness and pulse-wave velocity in patients with coronary artery disease
artículo científico publicado en 2013
Inflammation in atrial fibrillation
artículo científico publicado en 2012
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation
scientific article published on 01 October 2004
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
artículo científico publicado en 2002
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study
artículo científico publicado en 2004
Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism
artículo científico publicado en 2015
Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment
scientific article published on 01 May 2010
Influence of Atrial Fibrillation on Plasma Von Willebrand Factor, Soluble E-Selectin, and N-Terminal Pro B-type Natriuretic Peptide Levels in Systolic Heart Failure
artículo científico publicado en 2008
Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program
artículo científico publicado en 2020
Influence of age on respiratory modulation of muscle sympathetic nerve activity, blood pressure and baroreflex function in humans.
artículo científico publicado en 2015
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study
artículo científico publicado en 2011
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation
scientific article published on 30 January 2008
Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists
artículo científico publicado en 2017
Initiation and persistence of warfarin or aspirin as thromboprophylaxis in chronic atrial fibrillation in general practice
artículo científico publicado en 2008
Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation
artículo científico publicado en 2018
Insights from the RCPE UK Consensus Conference on approaching the comprehensive management of atrial fibrillation
artículo científico
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
artículo científico publicado en 2010
Insights from the new European Society of Cardiology guidelines for the medical management of atrial fibrillation
⬇️
artículo científico publicado el 1 de noviembre de 2010
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort
scientific article published on 11 December 2018
Integrated care for the management of atrial fibrillation: what are the key components and important outcomes?
artículo científico publicado en 2019
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
artículo científico publicado en 2018
Integrating real-time clinical information to provide estimates of net clinical benefit of antithrombotic therapy for patients with atrial fibrillation.
artículo científico publicado en 2014
Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
artículo científico publicado en 2017
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes
artículo científico publicado en 2005
Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
artículo científico publicado en 2016
Interactions between clopidogrel and proton pump inhibitors: a review of evidence.
artículo científico publicado en 2011
Interleukin-15 in hypertension: further insights into inflammation and vascular disease
artículo científico publicado en 2005
Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes
artículo científico publicado en 2012
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation
artículo científico publicado en 2003
Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis
artículo científico publicado en 2003
Interleukin-8 and atrial fibrillation
artículo científico publicado en 2008
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
artículo científico publicado en 2020
International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives
artículo científico publicado en 2016
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
artículo científico publicado en 2011
Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation
⬇️
artículo científico publicado en 2017
Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation
scientific article published on 01 December 2011
Intracerebral Hemorrhage and Warfarin
artículo científico publicado en 2011
Intracerebral haemorrhage, atrial fibrillation, and anticoagulation.
artículo científico publicado en 2015
Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2015
Intravenous water-soluble amiodarone improved 24-hour survival in incessant ventricular tachycardia
artículo científico publicado el 1 de mayo de 2003
Introducing Our New Offspring Journal … TH Open
artículo científico publicado en 2017
Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
scientific article published on 05 November 2019
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials
artículo científico publicado en 2017
Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?
artículo científico publicado en 2016
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?
artículo científico publicado en 2005
Is angiotensin receptor blockade antithrombotic?
artículo científico publicado en 2003
Is atrial fibrillation an inflammatory disorder?
artículo científico publicado en 2005
Is atrial fibrillation another manifestation of organ damage in diabetes?
artículo científico publicado en 2017
Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation
artículo científico
Is depression following acute myocardial infarction an independent risk for mortality?
artículo científico publicado en 2004
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
artículo científico
Is hypertension a prothrombotic state?
artículo científico publicado en 2005
Is hypertension an inflammatory process?
artículo científico publicado en 2006
Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for?
artículo científico publicado en 2007
Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
artículo científico publicado en 2003
Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke?
artículo científico publicado en 2016
Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?
artículo científico publicado en 2011
Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
artículo científico publicado en 2007
Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?
artículo científico publicado en 2016
Is the higher risk of cardiovascular disease amongst South Asian populations linked to abnormalities of haemoglobin? A preliminary case control study
artículo científico publicado en 2012
Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?
artículo científico publicado en 2002
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
artículo científico publicado en 2003
Is thrombogenesis related to residual platelet function in ischaemic heart disease?
scientific article published on 25 October 2008
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2016
Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients
artículo científico publicado en 2011
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis
artículo científico publicado en 2015
Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions
artículo científico publicado en 2020
Ischemic stroke and atrial fibrillation--a deadly serious combination
artículo científico publicado en 2011
Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
artículo científico publicado en 2014
Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features
artículo científico publicado en 2009
Ischemic stroke risk in East Asian patients with CHA2DS2-VASc score of 1: systematic review and meta-analysis
artículo científico publicado en 2017
Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile
artículo científico publicado en 2019
Knowledge, communication and expectancies of cardiac catheterization: The patient's perspective
artículo científico publicado en 2002
LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention
artículo científico publicado en 2015
LIFE: losartan versus atenolol.
artículo científico publicado en 2003
Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
scientific article published on 04 June 2020
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis
artículo científico publicado en 2016
Laboratory investigation of platelets
artículo científico publicado en 2001
Laboratory monitoring of the non-vitamin K oral anticoagulants
artículo científico publicado en 2014
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials
artículo científico publicado en 2015
Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study
artículo científico publicado en 2012
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels
artículo científico publicado en 2010
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial
artículo científico publicado en 2016
Left Ventricular Thrombosis: New Perspectives on an Old Problem
scientific article published on 22 June 2020
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey
artículo científico publicado en 2013
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
artículo científico publicado en 2016
Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
artículo científico publicado en 2009
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
artículo científico publicado en 2016
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)
scientific article published on 01 September 2018
Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study
⬇️
artículo científico publicado en 2018
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment
Left ventricular ejection fraction: are the revised cut-off points for defining systolic dysfunction sufficiently evidence based?
artículo científico publicado en 2008
Left ventricular fibrosis in atrial fibrillation
artículo científico publicado en 2013
Left ventricular geometry and outcomes in patients with atrial fibrillation: the AFFIRM Trial
artículo científico publicado en 2013
Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy
artículo científico publicado en 2012
Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management
artículo científico publicado en 2004
Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?
artículo científico publicado en 2006
Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2020
Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation"
artículo científico publicado en 2020
Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial"
scientific article published on 10 June 2019
Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation"
artículo científico publicado en 2020
Letter by Nielsen et al Regarding Article, "Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis"
artículo científico publicado en 2016
Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass"
artículo científico publicado en 2008
Letter by Shahid and Lip Regarding Article, "Stroke Risk Factors Unique to Women"
scientific article published on 01 September 2018
Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation
artículo científico publicado en 2015
Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties
artículo científico publicado en 2010
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more
scientific article published on 07 April 2020
Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation: A Report From the Taiwan Nationwide AF Cohort Study
artículo científico publicado en 2017
Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study
scientific article published on 06 September 2020
Lipid lowering and the assessment of endothelial function
artículo científico publicado en 2002
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
artículo científico publicado en 2017
Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries
artículo científico publicado en 2004
Localized retinal nerve fiber layer defects and arterial hypertension: insights into pathophysiology and perhaps an eye for detail?
artículo científico publicado en 2013
Lone atrial fibrillation - an overview
artículo científico
Lone atrial fibrillation: what do we know?
artículo científico publicado en 2009
Lone atrial fibrillation: what is known and what is to come
⬇️
artículo científico publicado el 11 de enero de 2011
Lone atrial fibrillation: where are we now?
artículo científico publicado en 2011
Long-Term Impact of Newly Diagnosed Atrial Fibrillation During Critical Care: A South Korean Nationwide Cohort Study
scientific article published on 30 April 2019
Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry
article
Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.
artículo científico publicado en 2016
Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use
artículo científico publicado en 2019
Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores
artículo científico publicado en 2017
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
artículo científico
Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
artículo científico publicado en 2017
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.
artículo científico publicado en 2013
Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the fushimi AF registry
artículo científico publicado en 2020
Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data
scientific article published on 09 November 2020
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis
scientific article published on 02 January 2021
Longer term stroke risk in intracerebral haemorrhage survivors
scientific article published on 17 June 2020
Looking through the PRISM: New Insights for Young Patients with Atrial Fibrillation and Stroke
artículo científico publicado en 2011
Low Body Weight Increases the Risk of Ischemic Stroke and Major Bleeding in Atrial Fibrillation: The COOL-AF Registry
scientific article published on 22 August 2020
Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial
artículo científico publicado en 2013
Low volume-high intensity interval exercise elicits antioxidant and anti-inflammatory effects in humans
artículo científico publicado en 2015
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
scientific article published on 30 August 2020
Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation
scientific article published on 10 July 2019
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment
artículo científico publicado en 2003
Maintaining therapeutic anticoagulation: the importance of keeping "within range"
artículo científico publicado en 2007
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
artículo científico publicado en 2016
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials
artículo científico publicado en 2016
Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study
artículo científico publicado en 2018
Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States
artículo científico publicado en 2016
Malignant Hypertension Revisited-Does This Still Exist?
artículo científico publicado en 2017
Malignant hypertension: a rare problem or is it underdiagnosed?
artículo científico publicado en 2010
Malignant hypertension: does this still exist?
scientific article published on 21 October 2019
Malignant hypertension: not quite an obsolete diagnosis yet
scientific article published on 01 February 2019
Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
article by Gregory Lip et al published 30 September 2009 in Thrombosis and Haemostasis
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review
artículo científico publicado en 2019
Management of Atrial Fibrillation in Patients With Kidney Disease
artículo científico publicado en 2014
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group
scientific article published on 22 October 2019
Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey
artículo científico publicado en 2014
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:
artículo científico publicado en 2008
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis.
artículo científico publicado en 2016
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI: A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, Eur
scientific article published on 01 August 2018
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro
artículo científico publicado en 2014
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society
artículo científico publicado en 2019
Management of atrial fibrillation
artículo científico publicado en 2007
Management of atrial fibrillation
artículo científico publicado en 2006
Management of atrial fibrillation
artículo científico publicado en 2006
Management of atrial fibrillation
artículo científico publicado en 2007
Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-ba
artículo científico publicado en 2020
Management of atrial fibrillation in specific patient populations
artículo científico publicado en 2015
Management of atrial fibrillation – Authors' reply
artículo científico publicado en 2007
Management of atrial fibrillation: easy as ABC
artículo científico publicado en 2018
Management of atrial fibrillation: the NICE guidelines
artículo científico publicado en 2007
Management of hypertension in relation to acute coronary syndromes and revascularisation
artículo científico publicado en 2007
Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey
scientific article published on 28 December 2019
Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention
artículo científico publicado en 2008
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability
artículo científico publicado en 2005
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
artículo científico publicado en 2009
Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors
artículo científico publicado en 2015
Matrix Metalloproteinases and the Extracellular Matrix
artículo científico publicado en 2007
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy
scientific article published on 01 August 2004
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
artículo científico publicado en 2004
Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction?
artículo científico publicado en 2006
Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications
artículo científico publicado en 2012
Matrix metalloproteinases in atrial fibrillation
artículo científico publicado en 2004
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance
artículo científico publicado en 2005
May your New Year be happy and prosperous with “Thrombosis and Haemostasis”
scholarly article by Gregory Lip & Christian Weber published January 2016 in Thrombosis and Haemostasis
Measurement of C-reactive protein and natriuretic peptides for cardiovascular risk assessment: the need for age and gender-specific thresholds
artículo científico publicado en 2008
Measurement of defect angle in superior semicircular canal dehiscence
scientific article published on 08 August 2009
Measurement of rivaroxaban and apixaban in serum samples of patients
artículo científico publicado en 2014
Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification
artículo científico publicado en 2008
Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay
artículo científico publicado en 2003
Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?
artículo científico publicado en 2007
Mechanisms of thrombogenesis in atrial fibrillation – Authors' reply
artículo científico publicado en 2009
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
artículo científico publicado en 2009
Meet the Editorial Board
artículo científico publicado en 2015
Meeting the unmet needs to improve management and outcomes of patients with atrial fibrillation: fitting global solutions to local settings
artículo científico publicado en 2019
Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban
artículo científico
Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation
scientific article published on 25 June 2019
Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention.
artículo científico publicado en 2016
Metabolic syndrome and renal disease
artículo científico publicado en 2012
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
artículo científico
Metabolic syndrome: a definition in progress.
artículo científico publicado en 2004
Microparticles and cardiovascular diseases
artículo científico publicado en 2019
Misconceptions on Interpretation of Risk Prediction Tools in Atrial Fibrillation
artículo científico publicado en 2016
Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation
artículo científico
Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study
artículo científico publicado en 2011
Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis
artículo científico publicado en 2009
Mobile Health (mHealth) technology for improved screening, patient involvement and optimizing integrated care in atrial fibrillation: The mAFA (mAF-App) II randomized trial
article
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial
artículo científico publicado en 2017
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
scientific article published on 01 April 2020
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
artículo científico publicado en 2020
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
scientific article published on 02 September 2019
Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation
artículo científico publicado en 2020
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort
scientific article published on 13 October 2020
Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death
artículo científico publicado en 2017
Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives
artículo científico publicado en 2016
Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction
artículo científico publicado en 2014
Modern management of atrial fibrillation.
artículo científico publicado en 2007
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study
artículo científico publicado en 2013
Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study
artículo científico publicado en 2014
Mon2 predicts poor outcome in ST-elevation myocardial infarction
scientific article published on 15 January 2019
Monitoring changes in thioredoxin and over-oxidised peroxiredoxin in response to exercise in humans
artículo científico publicado en 2015
Monitoring in the management of atrial fibrillation
artículo científico publicado en 2012
Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants
artículo científico publicado en 2015
Monocyte diversity in myocardial infarction
scientific article published on 01 July 2009
Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis
artículo científico publicado en 2014
Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure
artículo científico publicado en 2012
Monocyte-platelet cross-talk in peripheral artery disease-how much does the pathogenesis of atherosclerosis depend on anatomical location?
Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner
artículo científico publicado en 2013
Monocytes in acute coronary syndromes
artículo científico publicado en 2009
Monocytes in coronary artery disease and atherosclerosis: where are we now?
artículo científico publicado en 2013
Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?
artículo científico publicado en 2009
Monocytes: possible mediators of benefits and harms from physical activity?
artículo científico publicado en 2011
Mortality in congestive heart failure complicated by atrial fibrillation
artículo científico publicado en 2004
Mortality in patients with atrial fibrillation: improving or not?
artículo científico publicado en 2008
Moving forward with a new editorial team for Thrombosis and Haemostasis
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT
artículo científico publicado en 2009
Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke.
artículo científico publicado en 2016
Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project
artículo científico publicado en 2018
Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke.
artículo científico publicado en 2015
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
artículo científico publicado en 2019
My Approach to the use of NOACs for stroke prevention in patients with atrial fibrillation
artículo científico publicado en 2014
Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin
artículo científico publicado en 2013
Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea
artículo científico publicado en 2011
NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study
artículo científico publicado en 2018
Nebivolol for the treatment of heart failure
artículo científico
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection
artículo científico publicado en 2003
Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)
artículo científico publicado en 2015
Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range.
artículo científico publicado en 2016
Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population
artículo científico publicado en 2015
Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry
artículo científico publicado en 2016
Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study
artículo científico publicado en 2014
Net clinical benefit of edoxaban versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
artículo científico publicado en 2015
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
artículo científico publicado en 2012
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study
artículo científico publicado en 2012
Neurovascular coupling and cerebral autoregulation in atrial fibrillation
scientific article published on 19 August 2019
New Oral Anti-Coagulants for Atrial Fibrillation: Will We Say Good Bye to Warfarin?
artículo científico publicado en 2011
New Oral Anticoagulants
artículo científico publicado en 2013
New advances in the treatment of atrial fibrillation: focus on stroke prevention
artículo científico publicado en 2014
New antiarrhythmic agents for atrial fibrillation
artículo científico publicado en 2004
New anticoagulant treatments to protect against stroke in atrial fibrillation
artículo científico
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
artículo científico publicado en 2009
New anticoagulants for venous thromboembolism and atrial fibrillation: what the future holds
artículo científico publicado en 2017
New anticoagulation drugs for atrial fibrillation
artículo científico publicado en 2011
New antiplatelet drugs: beyond aspirin and clopidogrel
artículo científico publicado en 2009
New approaches to therapy with omega-3 fatty acids
artículo científico publicado en 2008
New biomarkers and risk stratification in atrial fibrillation: simplicity and practicality matter
artículo científico publicado en 2014
New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation
⬇️
artículo científico publicado el 1 de diciembre de 2010
New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers
scientific article published on 01 January 2007
New insights on endothelial progenitor cell subpopulations and their angiogenic properties
scientific article published on 01 February 2008
New oral anticoagulant drugs in cardiovascular disease
artículo científico publicado en 2010
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
artículo científico
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper
artículo científico publicado en 2012
New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials
artículo científico publicado en 2014
New oral anticoagulants in heart failure
artículo científico publicado en 2013
New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
artículo científico publicado en 2017
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
artículo científico
Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.
artículo científico publicado en 2018
No effect of clopidogrel activity or cessation on vascular function or markers of inflammation
artículo científico publicado en 2012
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
artículo científico publicado en 2019
Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
artículo científico
Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease
artículo científico publicado en 2019
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
artículo científico publicado en 2015
Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function
artículo científico publicado en 2019
Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study
artículo científico publicado en 2021
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding
scientific article published on 08 January 2021
Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
scientific article published on 04 October 2019
Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide
artículo científico publicado en 2018
Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease
artículo científico publicado en 2016
Non-steroidal anti-inflammatory drugs and incident atrial fibrillation
artículo científico publicado en 2015
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy
artículo científico publicado en 2015
Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction
artículo científico publicado en 2017
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal
artículo científico publicado en 2014
Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism
artículo científico publicado en 2016
Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials
artículo científico publicado en 2015
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
artículo científico publicado en 2014
Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes
artículo científico publicado en 2014
Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
artículo científico publicado en 2019
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation and venous thromboembolism: where are we now?
artículo científico publicado en 2014
Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.
artículo científico publicado en 2015
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study
artículo científico publicado en 2020
Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology
artículo científico publicado en 2014
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation
artículo científico publicado en 2017
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark
scientific article published on 11 August 2016
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
scientific article published on 01 October 2018
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
scientific article published on 15 September 2020
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
artículo científico publicado en 2014
Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease
artículo científico publicado en 2016
Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation
artículo científico publicado en 2015
Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.
artículo científico publicado en 2019
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction
artículo científico publicado en 2018
Not all thromboembolism comes from the left atrial appendage in atrial fibrillation
artículo científico publicado en 2015
Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation
artículo científico publicado en 2019
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial
scientific article published on 11 November 2019
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
artículo científico publicado en 2017
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil
artículo científico publicado en 2009
Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments
artículo científico publicado en 2010
Novel biomarker-based risk prediction for new onset atrial fibrillation in patients with ST elevation myocardial infarction: Balancing simplicity and practicality
scientific article published on 01 April 2018
Novel concepts of statin therapy for cardiovascular risk reduction in hypertension
artículo científico publicado en 2006
Novel oral anticoagulants
artículo científico publicado en 2009
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban
artículo científico
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey
artículo científico publicado en 2013
Novel oral anticoagulants in cardiovascular disease
artículo científico publicado en 2013
Novel oral anticoagulants in non-valvular atrial fibrillation
artículo científico publicado en 2013
Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban
artículo científico
Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice
artículo científico publicado en 2010
Novel therapies for the prevention of stroke
artículo científico publicado en 2004
ORAL ANTICOAGULATION IN ATRIAL FIBRILLATION AND ANEMIA: A REPORT FROM DANISH NATIONWIDE REGISTRIES
artículo científico publicado en 2018
Obesity and Atrial Fibrillation: Making inroads through fat
artículo científico publicado en 2020
Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant
artículo científico publicado en 2020
Obstructive Sleep Apnea Is a Risk Factor for Stroke and Atrial Fibrillation: Response
artículo científico publicado en 2010
Obstructive sleep apnea and cardiovascular disease
artículo científico publicado en 2009
Obstructive sleep apnoea and metabolic syndrome: two sides of the same coin?
artículo científico publicado en 2008
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Clinical Outcomes in Asian Patients with Atrial Fibrillation
scientific article published on 20 July 2020
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy
artículo científico publicado en 2009
One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry
artículo científico publicado en 2020
One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry
artículo científico
One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry
scientific article published on 01 September 2018
Ongoing trials involving angiotensin-converting enzyme inhibitors
artículo científico publicado en 2002
Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand
scientific article published on 01 October 2020
Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function
scientific article published on 01 May 2019
Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study.
artículo científico publicado en 2018
Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat"
artículo científico publicado en 2011
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
artículo científico publicado en 2015
Optimisation of atrial fibrillation care - management strategies and quality measures
artículo científico publicado en 2020
Optimising stroke prevention in patients with atrial fibrillation
artículo científico publicado en 2015
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort
artículo científico publicado en 2015
Optimizing atrial fibrillation management: from ICU and beyond
artículo científico publicado en 2015
Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes
artículo científico publicado en 2015
Optimizing stroke prevention in elderly patients with atrial fibrillation.
artículo científico publicado en 2016
Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study
artículo científico publicado en 2020
Oral Anticoagulants for Non-Valvular Atrial Fibrillation In Frail Elderly Patients: Insights from the ARISTOPHANES Study
artículo científico publicado en 2020
Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
artículo científico publicado en 2015
Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage
artículo científico publicado en 2019
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
scientific article published on 28 February 2018
Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk
artículo científico
Oral anticoagulants for stroke prevention in atrial fibrillation
artículo científico publicado en 2014
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
artículo científico publicado en 2016
Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study
artículo científico publicado en 2019
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention
artículo científico publicado en 2013
Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'.
artículo científico publicado en 2017
Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?
artículo científico publicado en 2012
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting
artículo científico publicado en 2012
Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: Systematic review and meta-analysis of randomized controlled trials
scientific article published on 16 September 2019
Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score
artículo científico publicado en 2015
Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation Project.
artículo científico publicado en 2016
Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly
artículo científico publicado en 2012
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K an
artículo científico publicado el 18 de diciembre de 2010
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
artículo científico publicado en 2009
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients
artículo científico publicado en 2006
Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
artículo científico publicado en 2017
Outcome parameters for trials in atrial fibrillation: executive summary
artículo científico publicado en 2007
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
artículo científico publicado en 2007
Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control
artículo científico publicado en 2018
Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation
artículo científico publicado en 2017
Outcomes in VKA-Treated Patients with Atrial Fibrillation and Chronic Kidney Disease: Clinical Trials vs 'Real-World'
artículo científico publicado en 2020
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
artículo científico publicado en 2016
Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
scientific article published on 15 October 2020
Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).
artículo científico publicado en 2013
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry
artículo científico publicado en 2018
Oxidised LDL-lipids alter redox ratio, lipid raft formation and increase amyloid beta production by SHSY-5Y cells
Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation
artículo científico publicado en 2014
P-Wave Indices and Risk of Ischemic Stroke: A Systematic Review and Meta-Analysis
artículo científico publicado en 2017
PATTERNS OF NEWLY DETECTED ATRIAL FIBRILLATION AND ANTITHROMBOTIC TREATMENT IN NORTH AMERICA (GLORIA-AF PHASE II)
artículo científico publicado en 2015
PHYSICAL ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A REPORT FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME PILOT SURVEY ON ATRIAL FIBRILLATION (EORP-AF) GENERAL REGISTRY
artículo científico publicado en 2016
PP.29.27
artículo científico publicado en 2015
PREDICTING MAJOR BLEEDING IN PATIENTS WITH SYSTOLIC HEART FAILURE TREATED WITH WARFARIN OR ASPIRIN
artículo científico publicado en 2014
PREFACE
artículo científico publicado en 2007
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
artículo científico publicado en 2013
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis
scientific article published on 01 July 2008
Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation
artículo científico publicado en 2020
Patent foramen ovale and migraine attacks: a systematic review
artículo científico publicado en 2013
Pathophysiological insights into atrial fibrillation: revisiting electrophysiological substrate, anatomical substrate, and possible insights from proteomics
artículo científico publicado en 2020
Pathophysiology of Atrial Fibrillation and Chronic Kidney Disease
scientific article published on 01 September 2020
Patient Perceptions of Hypertension and its Treatment
⬇️
artículo científico publicado el 1 de enero de 2003
Patient care pathway, implementation and audit criteria for patients with atrial fibrillation
artículo científico publicado en 2006
Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project
scientific article published on 25 October 2005
Patient outcomes using the European label for dabigatran. A post-hoc analysis from the RE-LY database.
artículo científico publicado en 2013
Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study
artículo científico publicado en 2013
Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation
artículo científico publicado en 2014
Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study
artículo científico publicado en 2015
Patients with atrial fibrillation undergoing percutaneous coronary intervention. Current concepts and concerns: part I
artículo científico publicado en 2015
Patients with atrial fibrillation undergoing percutaneous coronary intervention: current concepts and concerns: part II
artículo científico publicado en 2014
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
artículo científico publicado en 2018
Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study
artículo científico publicado en 2017
Patients' understanding of anticoagulant therapy in a multiethnic population
scientific article published on 01 April 2003
Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project
artículo científico publicado en 2012
Patterns in atrial fibrillation management and ‘real-world’ adherence to guidelines in the Balkan Region: an overview of the Balkan–atrial fibrillation survey
artículo científico publicado en 2015
Percutaneous coronary intervention in anticoagulated patients and balancing the risk of stroke and bleeding: to interrupt or not to interrupt?
artículo científico publicado en 2010
Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy
artículo científico publicado en 2005
Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention
artículo científico publicado en 2014
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
artículo científico publicado en 2011
Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients
artículo científico publicado en 2012
Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with
artículo científico publicado en 2012
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.
artículo científico publicado en 2009
Peri-operative management of ophthalmic patients taking antithrombotic therapy
artículo científico publicado en 2011
Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis
artículo científico publicado en 2010
Peripheral arterial disease amongst British ethnic minorities in a community based population: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).
artículo científico publicado en 2017
Peripheral arterial disease and Virchow's triad
artículo científico publicado en 2009
Peripheral arterial disease in patients with atrial fibrillation: The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study
artículo científico publicado en 2020
Peripheral arterial disease: a high risk - but neglected - disease population
artículo científico publicado en 2005
Peripheral artery disease and atrial fibrillation: a potentially dangerous combination
artículo científico publicado en 2011
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
artículo científico publicado en 2020
Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality
artículo científico publicado en 2007
Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic
artículo científico publicado en 2010
Periprocedural and Long-Term Anticoagulation
artículo científico publicado en 2011
Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation
artículo científico publicado en 2012
Periprocedural antithrombotic management of patients undergoing ablation for atrial fibrillation: what we currently do...and what should we do?
artículo científico publicado en 2012
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
artículo científico publicado en 2017
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
artículo científico publicado en 2020
Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry
Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study
artículo científico publicado en 2017
Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension
⬇️
artículo científico publicado el 24 de enero de 2011
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference
artículo científico publicado en 2013
Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation
artículo científico
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.
artículo científico publicado en 2018
Pharmacokinetic considerations for antithrombotic therapies in stroke
artículo científico
Pharmacokinetics and pharmacodynamics of oral anticoagulants used in atrial fibrillation
scientific article published on 19 April 2019
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
artículo científico publicado en 2020
Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders.
artículo científico
Pharmacological modulation of platelet function in hypertension
artículo científico publicado en 2003
Pharmacotherapy for atrial fibrillation: is rhythm control achievable?
scientific article published on 01 June 2006
Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
artículo científico publicado en 2003
Physical fitness and the relationship between hypertension and markers of atherothrombosis
artículo científico publicado en 2007
Physician Estimation of Thrombotic and Bleeding Risks in Atrial Fibrillation: Let's Talk About Sex
scientific article published on 12 December 2018
Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project
artículo científico publicado en 2014
Plasma YKL-40 levels are elevated in patients with chronic heart failure
artículo científico publicado en 2010
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis
artículo científico publicado en 2007
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure
artículo científico publicado en 2004
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes
artículo científico publicado en 2004
Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study
artículo científico publicado en 2006
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor
scientific article published on 13 September 2010
Plasma indices of angiogenesis in rheumatoid disease: relationship to cardiovascular risk factors and cardiac function
artículo científico publicado en 2009
Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity
artículo científico publicado en 2008
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis
artículo científico
Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation
artículo científico publicado en 2005
Plasma markers of angiogenesis in pregnancy induced hypertension
artículo científico publicado en 2005
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes
scientific article published on 01 November 2005
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease
artículo científico publicado en 2005
Plasma metalloproteinase-9 in age-related macular degeneration
scientific article published on 21 March 2008
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention
artículo científico publicado en 2004
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma
artículo científico publicado en 2002
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study
artículo científico publicado en 2006
Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors
scientific article published on 01 October 2002
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension
artículo científico publicado en 2004
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
artículo científico publicado en 2011
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation
artículo científico publicado en 2004
Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation
artículo científico publicado en 2002
Platelet activation and cardiovascular outcomes in acute coronary syndromes
artículo científico publicado en 2006
Platelet activation in acute, decompensated congestive heart failure
scientific article published on 06 February 2007
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty
artículo científico publicado en 2007
Platelet activation in pregnancy-induced hypertension
artículo científico publicado en 2005
Platelet activation in the hypertensive disorders of pregnancy
artículo científico publicado en 2004
Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma
artículo científico publicado en 2004
Platelet activation, haemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation
artículo científico publicado en 2003
Platelet adhesion in atrial fibrillation
artículo científico publicado en 2007
Platelet adhesion in breast cancer: development and application of a novel assay
artículo científico publicado en 2004
Platelet adhesion in congestive heart failure
scientific article published on 17 September 2007
Platelet adhesion in hypertension: Application of a novel assay of platelet adhesion
artículo científico publicado en 2005
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion
artículo científico publicado en 2005
Platelet and Coagulation Abnormalities
artículo científico publicado en 2007
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
artículo científico publicado en 2004
Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke
artículo científico publicado en 2006
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers
artículo científico publicado en 2005
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy
artículo científico publicado en 2004
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project
scientific article published on 01 December 2004
Platelet reactivity in prolonged stress disorders--a link with cardiovascular disease?
artículo científico publicado en 2010
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm
artículo científico publicado en 2007
Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis
artículo científico publicado en 2004
Platelets and heart failure
artículo científico publicado en 2006
Platelets, atherosclerosis and the endothelium: new therapeutic targets?
⬇️
artículo científico publicado el 1 de noviembre de 2003
Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)
artículo científico publicado en 2016
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial.
artículo científico publicado en 2015
Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry
artículo científico publicado en 2020
Population health status of South Asian and African-Caribbean communities in the United Kingdom
artículo científico publicado en 2012
Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study
scientific article published on 15 May 2020
Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis
artículo científico publicado en 2005
Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA2DS2-VASc score
artículo científico publicado en 2014
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation
artículo científico publicado en 2007
Post-stroke inflammatory response: effects of stroke evolution and outcome
artículo científico publicado en 2003
Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
artículo científico publicado en 2017
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
artículo científico publicado en 2019
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey
artículo científico publicado en 2012
Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease
artículo científico
Practice-derived data on non-vitamin K antagonist oral anticoagulant therapy to complement observations from randomized trials
scientific article published on 15 September 2020
Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey
artículo científico publicado en 2012
Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery
artículo científico publicado en 2012
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
article
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE.
artículo científico publicado en 2016
Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project
artículo científico publicado en 2020
Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores
artículo científico publicado en 2018
Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study
artículo científico publicado en 2021
Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).
artículo científico publicado en 2016
Predicting recurrent atrial fibrillation after catheter ablation
artículo científico publicado en 2018
Predicting stroke in patients without atrial fibrillation
scientific article published on 18 March 2019
Predicting thrombotic events: Creating a complex approach for a complex condition
artículo científico publicado en 2008
Predicting thrombotic events: creating a complex approach for a complex condition
artículo científico publicado en 2008
Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort
artículo científico publicado en 2017
Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation
scientific article published in Scientific Reports
Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED.
artículo científico publicado en 2017
Prediction of stroke in patients without atrial fibrillation using the CHADS2 and CHA2DS2-VASc scores: a justification for more widespread thromboprophylaxis?
artículo científico publicado en 2014
Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score
artículo científico publicado en 2017
Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial
artículo científico publicado en 2016
Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy
artículo científico publicado en 2015
Predictive value of atrial high-rate episodes for arterial stiffness and endothelial dysfunction in dual-chamber pacemaker patients
artículo científico publicado en 2013
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation
scientific article published on 01 August 2004
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
artículo científico publicado en 2012
Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
artículo científico publicado en 2013
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study
artículo científico publicado en 2013
Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry
artículo científico publicado en 2015
Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry
artículo científico publicado en 2017
Predictors of diastolic dysfunction in ethnic groups: observations from the Hypertensive Cohort of The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).
artículo científico publicado en 2018
Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study
artículo científico publicado en 2016
Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers
artículo científico publicado en 2008
Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder?
artículo científico publicado en 2008
Prescribers' Compliance to Direct Oral Anticoagulants' Labels and Impact on Outcomes in Thailand
artículo científico publicado en 2020
Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study
artículo científico publicado en 2019
Prevalence and risk factors of silent brain infarcts in the population
artículo científico publicado en 2002
Prevalence of Hypertension in the Middle Belt of Ghana: A Community-Based Screening Study
scientific article published on 07 October 2019
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation
article
Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review
scientific article published on 31 December 2020
Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study
artículo científico publicado en 2012
Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)
artículo científico publicado en 2011
Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study
scientific article published on 17 October 2019
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
scientific article published on 09 March 2006
Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation
artículo científico publicado en 2015
Preventative Measures of Stroke in Patients With Atrial Fibrillation
artículo científico publicado en 2012
Preventing Thrombosis to Improve Outcomes in Heart Failure Patients
artículo científico
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation
artículo científico
Preventing stroke in atrial fibrillation: the SPORTIF programme
artículo científico publicado en 2005
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
artículo científico publicado en 2016
Prevention of Thromboembolism in Atrial Fibrillation Patients
artículo científico publicado en 2011
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
artículo científico publicado en 2006
Prevention of cardiovascular disease in clinical practice: The Joint British Societies' (JBS 2) guidelines
artículo científico publicado en 2006
Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis
artículo científico publicado en 2012
Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
artículo científico publicado en 2014
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
artículo científico publicado en 2012
Primary hyperaldosteronism
artículo científico publicado en 2003
Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
artículo científico publicado en 2014
Prior aspirin therapy and cardiovascular implantable electronic device infections
artículo científico publicado en 2012
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial
artículo científico publicado en 2017
Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project
artículo científico publicado en 2011
Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
artículo científico publicado en 2014
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study
artículo científico publicado en 2012
Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study.
artículo científico publicado en 2016
Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation.
artículo científico publicado en 2018
Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project
artículo científico publicado en 2018
Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation
artículo científico publicado en 2013
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
artículo científico publicado en 2004
Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.
artículo científico publicado en 2015
Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure
artículo científico publicado en 2003
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation
artículo científico publicado en 2003
Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy
artículo científico publicado en 2014
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.
artículo científico publicado en 2014
Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events
artículo científico publicado en 2018
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.
artículo científico publicado en 2013
Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT<sub>2</sub>R<sub>2</sub> score-guided strategy in anticoagulant-naïve Thai patients with atrial
publication published on 11 October 2021
Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.
artículo científico publicado en 2006
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study, Etc.
artículo científico publicado en 2003
Psychological factors in heart failure: a review of the literature
artículo científico publicado en 2002
Psychological interventions for depression in adolescent and adult congenital heart disease
artículo científico publicado en 2013
Psychological interventions for depression in adolescent and adult congenital heart disease
artículo científico publicado en 2003
Psychological interventions for depression in heart failure
artículo científico publicado en 2005
Psychosocial functioning of adults with congenital heart disease: a neglected area.
artículo científico publicado en 2003
Pulmonary Embolism As a Consequence of Ultrasonographic Examination of Extremities for Suspected Venous Thrombosis: A Systematic Review
artículo científico publicado en 2016
Pulmonary Embolism and Atrial Fibrillation: Two Sides of the Same Coin? A Systematic Review
artículo científico publicado en 2017
Pulse pressure and carotid atherosclerosis: an important link revisited?
artículo científico publicado en 2006
Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction
scientific article published on 23 February 2019
Pushing the envelope too far?
scientific article published on 01 November 2004
Quality indicators for the care and outcomes of adults with atrial fibrillation
scientific article published on 29 August 2020
Quality of anticoagulation control in atrial fibrillation
artículo científico publicado en 2010
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy
artículo científico publicado en 2015
Quality of life in adults with congenital heart disease
artículo científico publicado en 2002
Quality of life in older people with atrial fibrillation
artículo científico publicado en 2008
Quality of life in patients with atrial fibrillation: a systematic review
artículo científico publicado en 2006
Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
artículo científico publicado en 2017
Quantifying time in atrial fibrillation and the need for anticoagulation
artículo científico publicado en 2017
REAL WORLD COMPARISON OF MAJOR BLEEDING RISK AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON APIXABAN, WARFARIN, DABIGATRAN OR RIVAROXABAN: A 1:1 PROPENSITY-SCORE MATCHED ANALYSIS
artículo científico publicado en 2016
REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN
artículo científico publicado en 2016
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
artículo científico publicado en 2012
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
artículo científico publicado en 2011
Radiofrequency catheter ablation of atrial fibrillation and thromboembolic risk
scientific article published on 01 December 2008
Raised leptin concentrations among South Asian patients with chronic heart failure
artículo científico publicado en 2006
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices
artículo científico
Rate control in the medical management of atrial fibrillation
artículo científico publicado en 2006
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation
artículo científico publicado en 2017
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registr
artículo científico publicado en 2015
Rationale and design of the Chinese Atrial Fibrillation Registry Study
artículo científico publicado en 2016
Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study)
artículo científico publicado en 2009
Real-World Comparative Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants versus Warfarin in a Developing Country
artículo científico publicado en 2020
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis
artículo científico publicado en 2017
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis
artículo científico publicado en 2017
Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis
scientific article published on 01 December 2019
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review
artículo científico publicado en 2019
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
artículo científico publicado en 2018
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis
artículo científico publicado en 2016
Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation
artículo científico publicado en 2019
Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points?
artículo científico publicado en 2015
Recent advances in management of atrial fibrillation in patients with heart failure
artículo científico publicado en 2013
Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention
artículo científico publicado en 2016
Recent developments in atrial fibrillation
artículo científico publicado en 2005
Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke
artículo científico
Recent scientific documents from the European Heart Rhythm Association (EHRA)
artículo científico publicado en 2015
Receptors to interleukin-6 and adhesion molecules on circulating monocyte subsets in acute myocardial infarction
artículo científico publicado en 2013
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH: comment
artículo científico publicado en 2015
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
scientific article published on 01 April 2013
Recommendations on stroke prevention for patients having a CHA2DS2-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines
scientific article published on 25 February 2019
Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].
artículo científico publicado en 2005
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
artículo científico publicado en 2016
Recurrent Stroke: The Value of the CHA2DS2VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort
artículo científico publicado en 2015
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial
artículo científico publicado en 2014
Red vs White Thrombi: Treating the Right Clot Is Crucial
artículo científico publicado el 10 de noviembre de 2003
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.
artículo científico publicado en 2017
Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes
artículo científico publicado en 2019
Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints
artículo científico publicado en 2012
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores
artículo científico publicado en 2019
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
artículo científico publicado en 2009
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.
artículo científico publicado en 2017
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
artículo científico publicado en 2014
Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle
scientific article published on 29 January 2020
Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice
artículo científico publicado en 2016
Regular bleeding risk assessment associated with reduction in bleeding outcomes: The mAFA II randomised trial
scientific article published on 11 April 2020
Relation of Nonvalvular Atrial Fibrillation to Body Mass Index (from the SPORTIF Trials).
artículo científico publicado en 2016
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.
artículo científico publicado en 2018
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
artículo científico publicado en 2017
Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).
artículo científico publicado en 2017
Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial
artículo científico publicado en 2016
Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).
artículo científico publicado en 2012
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation
artículo científico publicado en 2005
Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation
artículo científico publicado en 2004
Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study
artículo científico publicado en 2014
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
scientific article published on 02 October 2020
Relation of platelet activation to coronary angiographic severity and collateralization
artículo científico publicado en 2005
Relation of quality of anticoagulation control with different management systems amongst patients with atrial fibrillation: Data from FANTASIIA Registry
artículo científico publicado en 2018
Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation
artículo científico publicado en 2013
Relation of the CHA2DS2-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study)
artículo científico publicado en 2019
Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
artículo científico publicado en 2012
Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials
artículo científico publicado en 2016
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
artículo científico publicado en 2003
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists
artículo científico publicado en 2015
Relationship between Renal Function, Fibrin Clot Properties and Lipoproteins in Anticoagulated Patients with Atrial Fibrillation
artículo científico publicado en 2022
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes
scientific article published on 21 April 2007
Relationship between coronary artery disease and atrial fibrillation still unclear. Authors' reply
artículo científico publicado en 2020
Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study
artículo científico publicado en 2021
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
artículo científico publicado en 2015
Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation
artículo científico publicado en 2016
Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial
artículo científico publicado en 2015
Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation
artículo científico publicado en 2018
Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke
artículo científico publicado en 2017
Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: Real-world data from the FANTASIIA registry
scientific article published on 05 June 2020
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.
artículo científico publicado en 2009
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial
artículo científico publicado en 2004
Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation
artículo científico publicado en 2009
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation
artículo científico publicado en 2004
Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation
artículo científico publicado en 2017
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
artículo científico publicado en 2007
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial
artículo científico publicado en 2019
Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation
artículo científico publicado en 2014
Relationship of troponin to incident atrial fibrillation occurrence, recurrence after radiofrequency ablation and prognosis: a systematic review, meta-analysis and meta-regression
scientific article published on 04 May 2018
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology
artículo científico publicado en 2008
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups
artículo científico publicado en 2015
Relative skeletal muscle mass and incident hypertension: associations, caveats, and future perspectives
artículo científico publicado en 2020
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study
artículo científico publicado en 2012
Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey
artículo científico
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
scientific article published on 01 August 2019
Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source
artículo científico publicado en 2018
Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study
artículo científico publicado en 2016
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries
artículo científico publicado en 2017
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
artículo científico publicado en 2015
Renal dysfunction and diastolic impairment among British ethnic minorities with hypertension: the Ethnic-Echocardiographic Heart of England Screening Study
artículo científico publicado en 2016
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry
artículo científico publicado en 2013
Renal function and aspirin resistance in patients with coronary artery disease
artículo científico publicado en 2012
Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
artículo científico publicado en 2014
Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry
artículo científico publicado en 2019
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial
artículo científico publicado en 2013
Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project
artículo científico publicado en 2013
Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
artículo científico publicado en 2013
Renal, endothelial function, warfarin management, and the CHADS2, CHA2DS2VASc and HAS-BLED scores inpredicting MACE in AF.
artículo científico publicado en 2015
Renin-angiotensin blockade in atrial fibrillation: where are we now?
artículo científico publicado en 2017
Renin-angiotensin blockade in diabetic retinopathy
artículo científico publicado en 2011
Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling
scientific article published on 01 July 2009
Repeated assessment of physical biomeasures or blood biomarkers for the definition of volume status and cardiac loading in LVSD.
artículo científico publicado en 2007
Reply
artículo científico publicado en 2006
Reply
artículo científico publicado en 2010
Reply
artículo científico publicado en 2008
Reply to 'Comment on 'Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized clinical trials' by Tse et al.'
scientific article published on 08 July 2018
Reply to: “Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke”
artículo científico publicado en 2015
Reply: A persisting dilemma for triple antithrombotic therapy: are we close to finding the correct answer?
artículo científico publicado en 2014
Reply: Apixaban Dosing in Chronic Kidney Disease: Differences Between U.S. and E.U. Labeling
artículo científico publicado en 2017
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials
artículo científico publicado en 2013
Reply: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease
scientific article published on 01 November 2019
Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening
artículo científico publicado en 2020
Reply: The Case of Dynamic CHA2DS2-VASc Score: Beyond Risk Prediction
artículo científico publicado en 2018
Reply: To PMID 22575324
scientific article published on 26 December 2012
Reply: To PMID 22858389.
artículo científico publicado en 2013
Reply: ankle-brachial index in patients with nonvalvular atrial fibrillation.
artículo científico publicado en 2013
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
artículo científico publicado en 2012
Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation
artículo científico publicado en 2007
Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial
artículo científico publicado en 2015
Resource utilization and outcomes in patients with atrial fibrillation: a case control study
artículo científico publicado en 2012
Response
Response
Response
Response
Response
Response
Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis"
artículo científico publicado en 2017
Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study"
artículo científico publicado en 2019
Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
artículo científico publicado en 2016
Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?"
artículo científico publicado en 2016
Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage"
artículo científico publicado en 2020
Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring"
scientific article published on 01 August 2016
Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
artículo científico publicado en 2016
Response to Ansell et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel". (Thromb Haemost 2014; 112: 841)
scientific article published on 14 August 2014
Response to Dr Kula: Asymptomatic hypoxia in a young pregnant lady--unusual presentation of atrial septal defect
artículo científico publicado en 2009
Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della So
artículo científico publicado en 2015
Response to Letter Regarding Article, “Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study”
Response to Letter by De Silva et al
Response to Magnesium and Vascular Dysfunction in Malignant Hypertension
Response to letter by Haft: Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation
Response to letter regarding article, "Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation".
artículo científico publicado en 2013
Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)"
artículo científico publicado en 2014
Response to letter to editor by Jolobe ‘Stroke risk might be specifically correlated with the burden of paroxysmal atrial fibrillation’
artículo científico publicado en 2008
Response to the letter by Dr Jolobe: “Risk factors and stroke risk stratification for atrial fibrillation: Limitations and new possibilities”
Response to: The Cause of the Arteriolar Injury in Malignant Hypertension
artículo científico publicado en 2017
Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study
artículo científico publicado en 2015
Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
artículo científico publicado en 2018
Restenosis after coronary stenting: the 'gender paradox'.
artículo científico publicado en 2003
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure
artículo científico publicado en 2017
Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks
artículo científico publicado en 2017
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2017
Retinal vein and artery occlusions: a risk factor for stroke in atrial fibrillation
artículo científico publicado en 2013
Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease
artículo científico publicado en 2017
Retinal vessel tortuosity measures and their applications
artículo científico publicado en 2012
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular
artículo científico publicado en 2015
Review article: proton pump inhibitors with clopidogrel - evidence for and against a clinically-important interaction
⬇️
artículo científico publicado el 8 de febrero de 2011
Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation
artículo científico publicado en 2006
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure
scientific article published on October 2009
Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?
artículo científico publicado en 2020
Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUS
artículo científico publicado en 2020
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 1
scientific article published on 25 April 2019
Revisiting the risks of incident atrial fibrillation: a narrative review. Part 2
artículo científico publicado en 2019
Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology
artículo científico publicado en 2005
Rheumatoid disease and the heart: from epidemiology to echocardiography
artículo científico publicado en 2005
Rhythm control agents and adverse events in patients with atrial fibrillation
scientific article published on 01 September 2010
Rhythm control and cardioversion
artículo científico publicado en 2006
Rhythm outcomes after catheter ablation of atrial fibrillation. Clinical implication of biomarkers
artículo científico
Risk Stratification Models in Atrial Fibrillation
artículo científico publicado en 2017
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
artículo científico publicado en 2018
Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study
artículo científico publicado en 2019
Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source
artículo científico publicado en 2016
Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation - A Nationwide Cohort Study
artículo científico publicado en 2017
Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study
artículo científico publicado en 2015
Risk assessment and management of atrial fibrillation patients with left atrial thrombus
artículo científico publicado en 2018
Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities
artículo científico publicado en 2008
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review
artículo científico publicado en 2007
Risk factors for mortality in acute myocardial infarction
artículo científico publicado en 2002
Risk factors for new-onset atrial fibrillation: A focus on Asian populations.
artículo científico publicado en 2018
Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project
artículo científico publicado en 2011
Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices.
artículo científico publicado en 2018
Risk of Arrhythmia and Sudden Death
artículo científico publicado en 2002
Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation
artículo científico publicado en 2015
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca
artículo científico publicado en 2015
Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study
artículo científico publicado en 2015
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort
artículo científico publicado en 2019
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2015
Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study.
artículo científico publicado en 2018
Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials
scientific article published on 13 November 2014
Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study
artículo científico publicado en 2018
Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong
artículo científico publicado en 2014
Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey
artículo científico publicado en 2012
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
artículo científico publicado en 2017
Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis
artículo científico publicado en 2013
Risk predictors for lone atrial fibrillation
artículo científico publicado en 2008
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry
artículo científico publicado en 2013
Risks and Outcomes of Gastrointestinal Malignancies in Anticoagulated Atrial Fibrillation Patients Experiencing Gastrointestinal Bleeding - A Nationwide Cohort Study
artículo científico publicado en 2020
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study
artículo científico publicado en 2009
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
article
Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort
scientific article published on 14 April 2020
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis
artículo científico publicado en 2017
Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus
artículo científico publicado en 2018
Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care
artículo científico publicado en 2016
Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation
artículo científico publicado en 2009
Rivaroxaban.
artículo científico publicado en 2007
Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".
artículo científico publicado en 2016
Role for machine learning in sex-specific prediction of successful electrical cardioversion in atrial fibrillation?
scientific article published on 01 June 2020
Role of Monocytes in Heart Failure and Atrial Fibrillation
artículo científico publicado en 2018
Role of cardiorespiratory fitness in cancer development: time for an update
artículo científico publicado en 2020
Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke
artículo científico publicado en 2018
Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment
artículo científico publicado en 2006
Role of microRNAs in cardiac remodelling: new insights and future perspectives
artículo científico
Role of the CHADS2 score in acute coronary syndromes: with or without atrial fibrillation
artículo científico publicado en 2012
Role of ticagrelor in clopidogrel nonresponders: resistance is futile?
artículo científico publicado en 2010
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study
artículo científico publicado en 2013
SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.
artículo científico publicado en 2014
SEX DIFFERENCES IN ANTITHROMBOTIC THERAPY: OBSERVATIONS FROM THE GLORIA-AF REGISTRY PROGRAM
artículo científico publicado en 2016
STROKE AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION WITH RESUMPTION OF ORAL ANTICOAGULATION FOLLOWING TRAUMATIC INJURY: A DANISH NATIONWIDE COHORT STUDY
artículo científico publicado en 2016
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program
artículo científico publicado en 2019
Safety and efficacy of abciximab in older adults undergoing percutaneous coronary intervention
artículo científico publicado en 2015
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
artículo científico publicado en 2015
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
artículo científico publicado en 2020
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
artículo científico publicado en 2018
Safety and efficacy of new anticoagulants in patients with heart failure
artículo científico
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach
artículo científico publicado en 2014
Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial
artículo científico publicado en 2018
Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula
artículo científico publicado en 2015
Safety of coronary artery bypass surgery during therapeutic oral anticoagulation
artículo científico publicado en 2011
Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management.
artículo científico publicado en 2019
Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis
artículo científico publicado en 2019
Safety of new oral anticoagulant drugs: a perspective
artículo científico publicado en 2014
Salt intake and Helicobacter pylori infection
artículo científico publicado en 2004
Salt-loading and nitric oxide inhibition after the menopause
artículo científico publicado en 2003
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
artículo científico publicado en 2017
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofi
artículo científico publicado en 2017
Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation
artículo científico publicado en 2018
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial
artículo científico publicado en 2007
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration
scientific article published on 25 November 2019
Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study
artículo científico publicado en 2018
Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand
artículo científico publicado en 2012
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry
artículo científico publicado en 2017
Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE)
scientific article published on 24 July 2018
Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997-2005).
artículo científico publicado en 2007
Seek referral to a heart rhythm specialist for atrial fibrillation
artículo científico publicado en 2012
Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation.
artículo científico publicado en 2015
Self-care and adherence to medication: a survey in the hypertension outpatient clinic
artículo científico publicado en 2008
Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry
artículo científico publicado en 2017
Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage
scientific article published on 23 September 2020
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project
artículo científico publicado en 2002
Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
artículo científico publicado en 2013
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
artículo científico publicado en 2014
Serum adiponectin in coronary heart disease: ethnic differences and relation to coronary artery disease severity
artículo científico publicado en 2005
Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk
artículo científico publicado en 2011
Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study
scientific article published on 25 October 2019
Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
artículo científico publicado en 2018
Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project
artículo científico publicado en 2015
Sex differences in risk of incident venous thromboembolism in heart failure patients
scientific article published on 21 August 2018
Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients
Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation
artículo científico publicado en 2018
Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation - The Fushimi AF Registry.
artículo científico publicado en 2017
Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation
artículo científico publicado en 2014
Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
artículo científico publicado en 2015
Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry
artículo científico publicado en 2019
Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
artículo científico publicado en 2020
Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
artículo científico publicado en 2019
Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation
artículo científico publicado en 2019
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure
artículo científico publicado en 2005
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial
artículo científico publicado en 2017
Short-term effects of screening for cardiovascular risk in the deaf community: a pilot study
artículo científico publicado en 2011
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
artículo científico publicado en 2016
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke
artículo científico publicado en 2016
Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation
artículo científico publicado en 2019
Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
artículo científico publicado en 2015
Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry
scientific article published on 12 November 2018
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
artículo científico publicado en 2008
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
artículo científico publicado en 2012
Should we reintroduce previous venous thromboembolism into decision-making for anticoagulation in atrial fibrillation? Insights from a nationwide cohort
artículo científico publicado en 2020
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients
scientific article published on 19 January 2007
Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients - Meta-Analysis
artículo científico publicado en 2017
Silent cerebral embolism after catheter ablation of atrial fibrillation
artículo científico publicado en 2011
Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score.
artículo científico publicado en 2015
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores
artículo científico publicado en 2010
Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores
Simultaneous computerised activation of the primary percutaneous coronary intervention pathway reduces out-of-hours door-to-balloon time but not mortality.
artículo científico publicado en 2015
Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.
artículo científico publicado en 2018
Single right coronary artery with congenital absence of left coronary system
artículo científico publicado en 2018
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia
artículo científico publicado en 2020
Small-size Microparticles as Indicators of Acute Decompensated State in Ischemic Heart Failure
artículo científico publicado en 2015
Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.
artículo científico publicado en 2013
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin
artículo científico publicado en 2014
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics
artículo científico
Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
artículo científico publicado en 2020
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention
artículo científico publicado en 2008
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention
artículo científico publicado en 2004
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty
scientific article published on 01 March 2005
Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature
artículo científico publicado en 2003
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation
artículo científico publicado en 2007
Soluble Fas and Fas ligand in pregnancy: influence of hypertension
artículo científico publicado en 2011
Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.
artículo científico publicado en 2018
Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype
scientific article published on 14 December 2007
Soluble adhesion molecules and coronary heart disease
artículo científico publicado en 2002
Soluble fms-like tyrosine kinase-1 – a novel marker for atherosclerotic progression? –.
artículo científico publicado en 2010
Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis?
artículo científico publicado en 2011
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers
artículo científico publicado en 2005
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure
artículo científico publicado en 2009
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients
artículo científico publicado en 2006
Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation
artículo científico publicado en 2014
Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS-AF Trial
scientific article published on 10 September 2020
Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial
scientific article published on 22 November 2018
Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
artículo científico
Stanowisko ESC dotyczące toksycznego wpływu leczenia onkologicznego na układ sercowo-naczyniowy w 2016 roku, opracowane pod auspicjami Komisji ESC do spraw Wytycznych Postępowania
artículo científico publicado en 2016
Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials
artículo científico
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?
artículo científico publicado en 2007
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials
artículo científico publicado en 2015
Statin treatment is associated with improved prognosis in patients with AF-related stroke
artículo científico publicado en 2014
Statins and inflammation: reciprocal effectors to endothelial progenitors?
artículo científico publicado en 2008
Statins and intra-plaque angiogenesis in carotid artery disease
artículo científico publicado en 2007
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting
scientific article published on 07 November 2005
Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis.
artículo científico publicado en 2010
Statins and the assessment of endothelial function
artículo científico publicado en 2002
Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study
artículo científico publicado en 2015
Statins in women: Is primary prevention beneficial?
artículo científico publicado en 2005
Strategies to improve oral anticoagulation management
artículo científico publicado en 2011
Streamlining primary and secondary care management pathways for stroke prevention in atrial fibrillation
scientific article published on 01 October 2017
Stroke And Bleeding Risk Assessment: Where Are We Now?
artículo científico publicado en 2014
Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions
artículo científico publicado en 2014
Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients.
artículo científico publicado en 2018
Stroke Prevention in Atrial Fibrillation: Focus on Latin America
artículo científico publicado en 2016
Stroke Prevention in Atrial Fibrillation: Where are We Now?
artículo científico publicado en 2012
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines
scientific article published on 21 February 2019
Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation
scientific article published on 01 July 2018
Stroke Risk Factors Beyond the CHA₂DS₂-VASc Score: Can We Improve Our Identification of "High Stroke Risk" Patients With Atrial Fibrillation?
artículo científico
Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy
artículo científico publicado en 2018
Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study
artículo científico publicado en 2011
Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
artículo científico publicado en 2020
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
article by Jonas Bjerring Olesen et al published 16 August 2012 in The New England Journal of Medicine
Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation
artículo científico publicado en 2015
Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation
artículo científico publicado en 2019
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores
artículo científico publicado en 2020
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
artículo científico
Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey
artículo científico publicado en 2014
Stroke and bleeding risk in atrial fibrillation
artículo científico publicado en 2014
Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more).
artículo científico publicado en 2014
Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study
artículo científico publicado en 2019
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
artículo científico publicado en 2020
Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom
artículo científico publicado en 2016
Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
artículo científico publicado en 2012
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
artículo científico publicado en 2015
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
artículo científico publicado en 2016
Stroke and thromboembolism in atrial fibrillation
artículo científico publicado en 2012
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
artículo científico publicado en 2008
Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation
artículo científico publicado en 2008
Stroke in Heart Failure
artículo científico publicado en 2020
Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis.
artículo científico publicado en 2015
Stroke in atrial fibrillation: epidemiology and thromboprophylaxis
artículo científico publicado en 2011
Stroke prevention
artículo científico publicado en 2004
Stroke prevention
artículo científico publicado en 2003
Stroke prevention
scientific article published on 01 December 2002
Stroke prevention
artículo científico publicado en 2002
Stroke prevention
artículo científico publicado en 2008
Stroke prevention in Asian patients with atrial fibrillation
artículo científico publicado en 2014
Stroke prevention in Atrial Fibrillation
artículo científico publicado en 2017
Stroke prevention in atrial fibrillation
artículo científico publicado en 2016
Stroke prevention in atrial fibrillation and 'real world' adherence to guidelines in the Balkan Region: The BALKAN-AF Survey
artículo científico publicado en 2016
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry
scientific article published on 10 March 2020
Stroke prevention in atrial fibrillation in heart failure
artículo científico publicado en 2013
Stroke prevention in atrial fibrillation patients
artículo científico publicado en 2010
Stroke prevention in atrial fibrillation--things can only get better
artículo científico publicado en 2007
Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making
artículo científico publicado en 2017
Stroke prevention in atrial fibrillation: State of the art
scientific article published on 19 September 2018
Stroke prevention in atrial fibrillation: Where are we now?
artículo científico publicado en 2015
Stroke prevention in atrial fibrillation: a systematic review
artículo científico publicado en 2015
Stroke prevention in atrial fibrillation: an Asian perspective
artículo científico publicado en 2014
Stroke prevention in atrial fibrillation: antiplatelet therapy revisited
artículo científico publicado en 2007
Stroke prevention in atrial fibrillation: changing concepts
artículo científico publicado en 2015
Stroke prevention in atrial fibrillation: comparison of recent international guidelines
artículo científico publicado en 2020
Stroke prevention in atrial fibrillation: concepts and controversies
artículo científico publicado en 2012
Stroke prevention in atrial fibrillation: do we still need warfarin?
artículo científico publicado en 2012
Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe
artículo científico publicado en 2018
Stroke prevention in atrial fibrillation: the case for ximelagatran
artículo científico publicado en 2005
Stroke prevention in elderly patients with non-valvular atrial fibrillation in the BALKAN-AF survey
scientific article published on 30 January 2020
Stroke prevention in non-valvular atrial fibrillation: can warfarin do better?
artículo científico publicado en 2011
Stroke prevention strategies in North American patients with atrial fibrillation: the GLORIA-AF registry program.
artículo científico publicado en 2018
Stroke prevention strategies in high-risk patients with atrial fibrillation
artículo científico publicado en 2020
Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
artículo científico publicado en 2016
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis
artículo científico publicado en 2006
Stroke prevention with oral anticoagulation therapy in patients with atrial fibrillation--focus on the elderly
artículo científico
Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?
artículo científico publicado en 2012
Stroke risk assessment in atrial fibrillation
artículo científico publicado en 2012
Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations
scientific article published on 12 July 2018
Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis
artículo científico publicado en 2014
Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population
artículo científico publicado en 2011
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely
artículo científico publicado en 2007
Stroke risk stratification in hypertrophic cardiomyopathy
artículo científico publicado en 2020
Stroke risk stratification in patients with heart failure and sinus rhythm
artículo científico publicado en 2022
Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives
artículo científico
Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
artículo científico publicado en 2018
Stroke-Related Visual Impairment; is There an Association with Atrial Fibrillation?
artículo científico publicado en 2020
Stroke/thromboembolism and intracranial hemorrhage in a real-world atrial fibrillation population: the Complications of Atrial Fibrillation in the Bologna Area (CAFBO) study
artículo científico publicado en 2014
Stroke: Insights into Thromboembolism Treatment and Prevention through the Decades
scientific article published on 04 April 2019
Stroke: ethnic differences do exist
artículo científico publicado en 2006
Stroke: secondary prevention
artículo científico publicado en 2010
Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study
artículo científico publicado en 2007
Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients
artículo científico publicado en 2012
Subclinical thyroid dysfunction and cardiac function amongst minority ethnic groups in the UK: a cross sectional study
artículo científico publicado en 2013
Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
artículo científico publicado en 2016
Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk
artículo científico publicado en 2006
Switching from a vitamin K antagonist to a NOAC
artículo científico publicado en 2015
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis
scientific article published on 01 December 2019
Sympathetic nerve activity during non-sustained ventricular tachycardia in chronic heart failure
artículo científico publicado en 2012
Symptom-to-door times in patients presenting with ST elevation myocardial infarction--do ethnic or gender differences exist?
artículo científico publicado en 2015
Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry
artículo científico publicado en 2017
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction
artículo científico publicado en 2010
Systemic and intracardiac vascular endothelial growth factor and angiopoietin‐1 and ‐2 levels in coronary artery disease: Effects of angioplasty
scholarly article by Rumi J. Jaumdally et al published January 2007 in Annals of Medicine
Systemic inflammation as a driver of vascular calcification: a proof of concept
artículo científico publicado en 2009
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
artículo científico publicado en 2017
Systolic heart failure in South Asians
artículo científico
THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA
artículo científico publicado en 2014
TLR4 expression on monocyte subsets in myocardial infarction
artículo científico publicado en 2012
TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).
artículo científico publicado en 2010
Tackling anti-coagulation under-prescription in the elderly
Tackling malignant hypertension: not so desperate now
scientific article published on 01 August 2002
Tamoxifen for breast-cancer prevention
artículo científico publicado en 2003
Target organ damage in hypertension: pathophysiology and implications for drug therapy
artículo científico publicado en 2006
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
artículo científico publicado en 2005
Tedisamil: a new novel antiarrhythmic
artículo científico publicado en 2004
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care.
artículo científico publicado en 2017
Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan
artículo científico publicado en 2016
Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study
scientific article published on 14 May 2020
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood
artículo científico publicado en 2006
Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study
scientific article published in PLoS ONE
Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
artículo científico publicado en 2017
Temporal trends of catheter ablation for patients with atrial fibrillation: a Korean nationwide population-based study
artículo científico publicado en 2020
Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation
artículo científico publicado en 2018
The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?
scientific article published on 01 April 2011
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation
scientific article published on 24 August 2020
The ABC pathway: an integrated approach to improve AF management.
artículo científico publicado en 2017
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: comment
artículo científico publicado en 2018
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study
artículo científico publicado en 2020
The Birmingham Rehabilitation Uptake Maximisation study (BRUM): a randomised controlled trial comparing home-based with centre-based cardiac rehabilitation
artículo científico publicado en 2008
The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction
scientific article published on 01 July 2012
The CD40-CD40L system in cardiovascular disease.
artículo científico publicado en 2011
The CHA2DS2-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?
scientific article published on 22 July 2020
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy
artículo científico publicado en 2012
The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke
artículo científico publicado en 2013
The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores
artículo científico publicado en 2017
The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis
artículo científico publicado en 2015
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
artículo científico publicado en 2017
The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods
artículo científico publicado en 2015
The Coagulation Pathway and Approaches to Anticoagulation
artículo científico publicado en 2013
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
scientific article published on 10 November 2020
The Effect of Integrated Care Management on Dementia in Atrial Fibrillation
artículo científico publicado en 2020
The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials
artículo científico publicado en 2017
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years
scientific article published on 15 June 2020
The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia
artículo científico publicado en 2017
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
artículo científico publicado en 2015
The HAS-BLED Score and Renal Failure: Response
artículo científico publicado en 2011
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
artículo científico publicado en 2013
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
artículo científico publicado en 2016
The HAS-BLED, ATRIA and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
artículo científico publicado en 2017
The Importance and Future of Population Screening for Atrial Fibrillation
artículo científico publicado en 2018
The Liverpool Centre for Cardiovascular Science
scientific article published on 01 March 2019
The METHRO trials
⬇️
artículo científico publicado el 1 de mayo de 2003
The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management
artículo científico publicado en 2019
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations
scientific article published on 31 December 2018
The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey
artículo científico
The Potential Role of Edoxaban in Stroke Prevention Guidelines
artículo científico publicado en 2014
The QRISK was less likely to overestimate cardiovascular risk than the Framingham or ASSIGN equations.
artículo científico publicado en 2008
The Reply
artículo científico publicado en 2011
The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study
artículo científico publicado en 2016
The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
artículo científico publicado en 2015
The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.
artículo científico publicado en 2015
The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists
artículo científico publicado en 2015
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal
artículo científico publicado en 2019
The Yin-Yang of Atrial Fibrillation and Pulmonary Embolism
artículo científico publicado en 2016
The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?
scientific article published on 01 February 2010
The adhesion molecule P-selectin and cardiovascular disease
artículo científico publicado en 2003
The angiome: a new concept in cancer biology
scientific article published on 20 April 2011
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment
artículo científico publicado en 2005
The assessment of platelet activation in antiplatelet drug development
artículo científico publicado en 2005
The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
artículo científico publicado en 2010
The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study
artículo científico publicado en 2014
The atrial fibrillation epidemic: a validated diagnosis, or not?
artículo científico publicado en 2014
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited
artículo científico publicado en 2008
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure
artículo científico publicado en 2012
The contribution of cardiovascular risk factors to peripheral arterial disease in South Asians and Blacks: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study
article
The counterintuitive role of exercise in the prevention and cause of atrial fibrillation
artículo científico publicado en 2020
The effect of statin therapy withdrawal on monocyte subsets
artículo científico publicado en 2013
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood
scientific article published on 16 June 2007
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction
scientific article published on 28 November 2005
The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates
artículo científico publicado en 2012
The effects of exercise stress testing on soluble E‐selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction
The effects of exercise stress testing, diurnal variation and temporal decline on circulating progenitor cells
artículo científico publicado en 2009
The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure
scientific article published on 01 March 2008
The emerging role of biomarkers in atrial fibrillation
artículo científico publicado en 2013
The endotheliome: A new concept in vascular biology
⬇️
artículo científico publicado el 18 de diciembre de 2010
The endothelium and atrial fibrillation
The endothelium and thrombotic risk in heart failure
artículo científico publicado en 2009
The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity
artículo científico publicado en 2008
The endothelium, inflammation, and coagulation in sepsis
artículo científico publicado en 2006
The first prognostic model for stroke and death in patients with systolic heart failure
artículo científico publicado en 2015
The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe
artículo científico publicado en 2012
The heart in hypertension
artículo científico publicado en 2020
The hypercoagulable state of malignancy: pathogenesis and current debate
artículo científico publicado en 2002
The immunological axis in heart failure: importance of the leukocyte differential
artículo científico publicado en 2013
The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project
artículo científico publicado en 2015
The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review
artículo científico publicado en 2013
The impact of different glycaemic index carbohydrate staple foods on south asian diabetic and cardiovascular indices of health: A RCT
artículo científico publicado en 2015
The impact of dilated left atrium on rhythm control in patients with newly diagnosed persistent atrial fibrillation: the Belgrade atrial fibrillation project
scientific article published on 01 November 2011
The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review
artículo científico publicado en 2014
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation
artículo científico publicado en 2010
The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study
artículo científico publicado en 2014
The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials.
artículo científico publicado en 2015
The impact of statin use on atrial fibrillation
artículo científico publicado en 2008
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation
scientific article published on 23 April 2020
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden
artículo científico
The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries.
artículo científico publicado en 2011
The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study
artículo científico publicado en 2013
The membrane expression of P-selectin, but not monocyte-platelet aggregates, is influenced by variability in response to aspirin in patients with coronary artery disease
artículo científico publicado en 2012
The new NICE guideline on atrial fibrillation management
artículo científico publicado en 2006
The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
artículo científico publicado en 2017
The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease
artículo científico publicado en 2011
The number needed to treat for net effect (NNTnet) as a metric for measuring combined benefits and harms
artículo científico publicado en 2020
The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients
artículo científico publicado en 2020
The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview
artículo científico publicado en 2014
The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection
artículo científico publicado en 2020
The potential impact of periodontal disease on general health: a consensus view
scientific article published on 30 April 2008
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors
artículo científico publicado en 2017
The potential role of platelet microparticles in atherosclerosis
artículo científico publicado en 2005
The prevalence and persistence of depression and anxiety following myocardial infarction
artículo científico publicado en 2002
The prognostic role of the adiponectin levels in atrial fibrillation
artículo científico publicado en 2012
The prognostic value of biomarkers after a premature myocardial infarction
artículo científico publicado en 2009
The prothrombotic state in atrial fibrillation: pathophysiological and management implications
artículo científico publicado en 2019
The prothrombotic state in atrial fibrillation: the atrium, the endothelium... And tissue factor?
artículo científico publicado en 2003
The prothrombotic state in hypertension and the effects of antihypertensive treatment
artículo científico publicado en 2003
The quest for circulating endothelial cell standardization: the peril of platelets
artículo científico publicado en 2007
The quest for new anticoagulants: from clinical development to clinical practice
artículo científico publicado en 2010
The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis
artículo científico publicado en 2008
The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set.
artículo científico publicado en 2018
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study
artículo científico publicado en 2017
The reply
artículo científico publicado en 2014
The risk of thromboembolism in heart failure: does it merit anticoagulation therapy?
artículo científico publicado en 2011
The role of aspirin for stroke prevention in atrial fibrillation
artículo científico publicado en 2011
The role of aspirin in carcinogenesis
artículo científico publicado en 2002
The role of aspirin in cardiovascular prevention: implications of aspirin resistance
artículo científico publicado en 2008
The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors?
artículo científico publicado en 2011
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management
artículo científico publicado en 2006
The role of inflammation in atrial fibrillation
artículo científico publicado en 2005
The role of inflammation in atrial fibrillation: increasing evidence in support of a novel concept
artículo científico publicado en 2006
The role of monocytes and inflammation in the pathophysiology of heart failure
artículo científico publicado en 2011
The role of monocytes in angiogenesis and atherosclerosis
artículo científico publicado en 2014
The role of monocytes in atherosclerotic coronary artery disease.
scientific article published on September 2010
The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms
artículo científico publicado en 2009
The safety of NOACs in atrial fibrillation patient subgroups: A narrative review
article
The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study
scientific article published on 01 January 2020
The search for new anticoagulants: dabigatran etexilate
artículo científico publicado en 2008
The unifying role of matrix metalloproteinases in atheroma and vascular stroke
artículo científico publicado en 2004
The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia
artículo científico publicado en 2012
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
artículo científico publicado en 2012
The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationw
artículo científico publicado en 2014
The wearable cardioverter-defibrillator: current technology and evolving indications
artículo científico publicado en 2016
The year in cardiology: arrhythmias and pacing
artículo científico publicado en 2020
Therapy for atrial fibrillation: new challenges
artículo científico publicado en 2006
Thoracoscopic Left Atrial Appendage Excision plus Ablation for Atrial Fibrillation to Prevent Stroke
artículo científico publicado en 2020
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
artículo científico publicado en 2012
Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention
artículo científico publicado en 2013
Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease
artículo científico publicado en 2020
Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study
artículo científico publicado en 2020
Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study
artículo científico publicado en 2015
Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
artículo científico publicado en 2019
Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study
scientific article published on 01 August 2019
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm
article by Piotr Ponikowski et al published 2012 in Thrombosis and Haemostasis
Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: A descriptive nationwide cohort study
artículo científico publicado en 2020
Thromboembolism associated with new anti-cancer treatment strategies in combination with conventional chemotherapy: new drugs, old risks?
artículo científico publicado el 1 de octubre de 2003
Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
artículo científico publicado en 2017
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity
artículo científico publicado en 2003
Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?
artículo científico publicado en 2010
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
artículo científico publicado en 2004
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension
artículo científico publicado en 2004
Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?
artículo científico publicado en 2007
Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
artículo científico publicado en 2006
Thrombosis and Haemostasis 2018 Editor's Choice Papers
artículo científico publicado en 2018
Thrombosis and Haemostasis 2019 Editor's Choice Papers
artículo científico publicado en 2020
Thrombosis and Haemostasis Wishes You a Happy New Year Ahead!
scientific article published on 31 December 2018
Thrombosis and Haemostasis: Past, present and future
artículo científico publicado en 2017
Thrombosis and Haemostasis: volume 100 and going strong ...
artículo científico publicado en 2008
Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy
artículo científico publicado en 2010
Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation
scientific article published on 01 December 2019
Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies
artículo científico publicado en 2005
Thrombotic complications in heart failure: an underappreciated challenge
artículo científico publicado en 2014
Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation
artículo científico publicado en 2015
Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation.
artículo científico publicado en 2015
Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry
artículo científico publicado en 2017
Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation
artículo científico publicado en 2018
Time trends in use of the CHADS and CHA DS VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference
artículo científico publicado en 2018
Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study
scientific article published on 29 December 2010
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
artículo científico publicado en 2004
To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation
artículo científico publicado en 2016
To the Editor- Patients with atrial fibrillation with hypertrophic cardiomyopathy: Do we need new stroke risk stratification?
scientific article published on 04 April 2019
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention
scientific article published on 01 October 2018
Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones
scientific article published on 01 January 2010
Towards Assigning Diagnosis Codes Using Medication History
Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal
artículo científico publicado en 2006
Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey
artículo científico publicado en 2018
Tratamiento anticoagulante y antiagregante plaquetario combinado en pacientes con fibrilación auricular
artículo científico publicado en 2009
Tratamiento antitrombótico y tipo de stent en pacientes con fibrilación auricular a los que se practica una intervención coronaria percutánea
artículo científico publicado en 2013
Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN-AF survey
artículo científico publicado en 2020
Treatment of Atrial Fibrillation in Patients With Chronic Kidney Disease: Is Stroke Prevention Worth the Risk?
artículo científico publicado en 2016
Treatment of hypertension in peripheral arterial disease
artículo científico publicado en 2013
Treatment of hypertension in peripheral arterial disease
artículo científico publicado en 2009
Treatment of hypertension in peripheral arterial disease
artículo científico publicado en 2003
Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis
scientific article published on 01 January 2012
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
artículo científico publicado en 2020
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score
artículo científico publicado en 2016
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
artículo científico publicado en 2010
Trends in antithrombotic management of patients with atrial fibrillation. A report from the Polish part of the EURObservational Research Programme - Atrial Fibrillation General Long-Term Registry
scientific article published on 24 January 2020
Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations
artículo científico publicado en 2009
Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
article
Triple or dual antithrombotic therapy post-percutaneous coronary intervention: Which one is better?
scientific article published on 29 August 2019
Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yet.
artículo científico publicado en 2015
Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
artículo científico publicado en 2020
Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria
artículo científico publicado en 2014
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
artículo científico publicado en 2017
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study
scientific article published on 01 October 2018
URINARY ISOPROSTANES PREDICT VASCULAR EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROSPECTIVE STUDY
artículo científico publicado en 2014
USING THE CHA2DS2-VASC SCORE TO PREDICT ISCHEMIC STROKE IN PATIENTS WITH INTRACEREBRAL HEMORRHAGE: A NATIONWIDE COHORT STUDY
artículo científico publicado en 2019
Understanding the global burden of atrial fibrillation and regional variations: we need improvement
artículo científico publicado en 2020
Underuse of oral anticoagulants in atrial fibrillation: a systematic review
artículo científico publicado en 2010
Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology?
artículo científico publicado en 2003
Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines
artículo científico publicado en 2009
Updated NICE guideline: management of atrial fibrillation (2014)
artículo científico publicado en 2014
Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs.
artículo científico publicado en 2013
Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study
artículo científico publicado en 2016
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation
artículo científico publicado en 2015
Urinary Biomarkers of Oxidative Stress in Atrial Fibrillation
Urinary biomarkers of oxidative stress in atrial fibrillation
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
artículo científico publicado en 2006
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
artículo científico publicado en 2016
Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response
artículo científico publicado en 2018
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
artículo científico publicado en 2015
Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?
artículo científico publicado en 2016
Use of novel oral anticoagulants in patients with heart failure
artículo científico publicado en 2014
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
artículo científico publicado en 2018
Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study
artículo científico publicado en 2015
Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase
artículo científico publicado en 2017
Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation
artículo científico publicado en 2012
Use of the HAS-BLED bleeding score in real-life settings
artículo científico publicado en 2014
Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence
artículo científico publicado en 2016
Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients treated with vitamin K antagonists: A review
artículo científico publicado en 2017
Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
artículo científico publicado en 2014
Usefulness of P Wave Duration in Embolic Stroke of Undetermined Source
scientific article published on 15 April 2020
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation
scientific article published on 22 August 2019
Usefulness of the CHADS-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation
artículo científico publicado en 2018
Usefulness of the NULL-PLEASE Score to predict survival in out-of-hospital cardiac arrest
scientific article published on 06 May 2020
Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea
artículo científico publicado en 2015
Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke
scientific article published on 20 June 2019
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.
artículo científico publicado en 2016
Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective
scientific article published on 01 March 2013
Using the CHA2DS2-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application
artículo científico publicado en 2015
Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation
artículo científico publicado en 2014
Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation
artículo científico publicado en 2013
Using the MB-LATER score for predicting arrhythmia outcome after catheter ablation for atrial fibrillation: The Guangzhou atrial fibrillation project
artículo científico publicado en 2018
Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response
VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY
artículo científico publicado en 2019
Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study
artículo científico publicado en 2016
Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation
artículo científico publicado en 2012
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
artículo científico publicado en 2011
Validation of the Edinburgh Claudication Questionnaire in 1st generation Black African-Caribbean and South Asian UK migrants: a sub-study to the Ethnic-Echocardiographic Heart of England Screening (E-ECHOES) study
artículo científico publicado en 2011
Validation of the MB-LATER score for prediction of late recurrence after catheter-ablation of atrial fibrillation
scientific article published on 11 August 2018
Validation of the Same-TT2R2 Score in a Multiethnic Cohort of Asian Patients with Atrial Fibrillation on Warfarin Therapy – A Multicenter Study
artículo científico publicado en 2017
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation
scientific article published on 07 November 2019
Validity of D-dimer tests for pulmonary embolism: Better to diagnose or exclude?
⬇️
artículo científico publicado el 1 de mayo de 2003
Valor predictivo de la escala CHA2DS2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante
artículo científico publicado en 2012
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
artículo científico publicado en 2018
Valvar heart disease and prosthetic heart valves
artículo científico publicado en 2002
Variability of response to antiplatelet therapy: what should we do next?
artículo científico publicado en 2009
Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches
artículo científico publicado en 2018
Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study
artículo científico publicado en 2016
Vascular and platelet responses to aspirin in patients with coronary artery disease
artículo científico publicado en 2012
Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?
artículo científico publicado en 2009
Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study
artículo científico publicado en 2012
Vascular endothelial growth factor and angiogenesis in heart failure
artículo científico publicado en 2005
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes
artículo científico publicado en 2002
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure
artículo científico publicado en 2002
Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
artículo científico publicado en 2003
Vascular imaging as a cardiovascular risk stratification tool in systemic lupus erythematosus.
artículo científico publicado en 2009
Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project
artículo científico publicado en 2012
Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system?
artículo científico publicado en 2006
Venous Thromboembolism in Patients with Liver Cirrhosis: Findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) Registry
scientific article published on 15 October 2019
Venous thromboembolism
artículo científico publicado en 2006
Venous thromboembolism prophylaxis strategies for patients undergoing elective total knee replacement
artículo científico publicado en 2019
Venous thromboembolism: pathophysiology, clinical features, and prevention
artículo científico publicado en 2002
Ventricular optimization of biventricular pacing: a systematic review
artículo científico publicado en 2008
Ventricular-arterial coupling in obstructive sleep apnea
artículo científico publicado en 2014
Vernakalant hydrochloride for the treatment of atrial fibrillation
artículo científico publicado en 2009
Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice
artículo científico publicado en 2020
Vernakalant hydrochloride to treat atrial fibrillation
artículo científico
Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry
artículo científico publicado en 2019
Viewpoint
artículo científico publicado en 2006
Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal
artículo científico publicado en 2017
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
artículo científico publicado en 2006
Virchow's triad revisited
artículo científico publicado en 2004
Virchow's triad revisited: blood constituents
artículo científico publicado en 2003
Vital exhaustion and cardiovascular disease: are circulating fibrinogen and D-dimer levels a plausible link?
artículo científico publicado en 2008
Vitamin D deficiency amongst minority ethnic groups in the UK: a cross sectional study
scientific article published on 07 November 2012
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials
scientific article published on 04 September 2019
Vitamin K Antagonists and Their Limitations
artículo científico publicado en 2013
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
scientific article published on 14 November 2013
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type
artículo científico publicado en 2015
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function
artículo científico publicado en 2011
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
artículo científico publicado en 2002
WHAT DO REAL WORLD DATA SAY ABOUT SAFETY AND RESOURCE USE OF ORAL ANTAGONISTS? EARLY ANALYSIS OF NEWLY ANTICOAGULATED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS USING EITHER APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN
artículo científico publicado en 2016
WORLDWIDE ORAL ANTICOAGULANT PRESCRIPTION PREVALENCE AND TRENDS IN PATIENTS WITH ATRIAL FIBRILLATION FROM A MULTI-NATIONAL COHORT: INSIGHTS FROM THE INTERNATIONAL COLLABORATIVE PARTNERSHIP FOR THE STUDY OF ATRIAL FIBRILLATION (INTERAF) COLLABORATIVE
artículo científico publicado en 2019
Warfarin and aspirin in patients with heart failure and sinus rhythm
artículo científico publicado en 2012
Warfarin for stroke prevention in atrial fibrillation: time to switch?
artículo científico publicado en 2013
Warfarin or novel oral anticoagulants for atrial fibrillation?
artículo científico publicado en 2013
Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
artículo científico
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
artículo científico publicado en 2007
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.
artículo científico publicado en 2014
Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply
artículo científico publicado en 2020
Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply
scientific article published on 01 April 2020
Welcome to a new year in Thrombosis and Haemostasis….
What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?
artículo científico publicado en 2008
What Cannot Be Missed: Important Publications on Electrophysiology in 2019
artículo científico publicado en 2020
What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?
scientific article published on 16 September 2020
What are the costs of atrial fibrillation?
artículo científico publicado en 2011
What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
⬇️
artículo científico publicado el 12 de enero de 2011
What do the guidelines suggest for non-vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?
artículo científico publicado en 2016
What do we do about atrial high rate episodes?
artículo científico publicado en 2020
What is the impact of the latest ACC/AHA and ESC/ESH guidelines on the management of hypertension in the UK?
scientific article published on 03 January 2020
What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
scientific article published on 01 January 2012
What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation?
⬇️
artículo científico publicado el 6 de diciembre de 2010
What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes
artículo científico publicado en 2015
Which drug should we use for stroke prevention in atrial fibrillation?
artículo científico
Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
artículo científico publicado en 2013
Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot Registries
scientific article published on 01 February 2020
White Matter Hyperintensities Improve Ischemic Stroke Recurrence Prediction
artículo científico publicado en 2016
White coat hypertension: not so benign after all?
scientific article published on 01 December 2003
Why is atrial fibrillation so frequent in hypertensive patients?
scientific article published on 23 September 2020
Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project
artículo científico publicado en 2007
Ximelagatran
artículo científico publicado en 2006
Ximelagatran for stroke prevention in atrial fibrillation
artículo científico publicado en 2005
Ximelagatran in the clinic: practical management of patients
artículo científico publicado en 2005
Ximelagatran: an eulogy
artículo científico publicado en 2006
[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]
artículo científico publicado en 2018
[2018 ESC/ESH Guidelines for the management of arterial hypertension]
artículo científico publicado en 2019
[Guidelines for cardiac pacing and cardiac resynchronization therapy]
scientific article published on 01 May 2008
[Guidelines in cardiac pacing and resynchronization therapy].
artículo científico publicado en 2007
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]
scientific article published on 01 July 2009
[Stroke: secondary prevention]
artículo científico publicado en 2004
ascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry
artículo científico publicado en 2020
miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients.
artículo científico publicado en 2016
sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation.
artículo científico publicado en 2015
β-Blocker Use in Pregnancy and the Risk for Congenital Malformations
scientific article published on 01 June 2019
β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study
artículo científico publicado en 2016
β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment
artículo científico publicado en 2013
‘2012 focused update of the ESC Guidelines for the management of atrial fibrillation’ [Eur Heart J (2012); 33(21):2719–2747]